Peter Barnes

Q: What Schools Are Affiliated With Peter Barnes

Peter Barnes is affiliated with the following schools: University of Cologne, Imperial College London, Royal Postgraduate Medical School, Georgetown University, Lund University, University of Groningen, University of California, San Francisco, University of Cambridge

Peter Barnes 's AcademicInfluence.com Rankings

Peter Barnes

Philosophy

#601

World Rank

#1182

Historical Rank

Logic

#50

World Rank

#155

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Peter Barnes Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Peter John Barnes, FRCP, FCCP, FMedSci, FRS is a British respiratory scientist and clinician, a specialist in the mechanisms and treatment of asthma and chronic obstructive pulmonary disease . He was Margaret Turner-Warwick Professor of Thoracic Medicine at the National Heart & Lung Institute, previous head of respiratory medicine at Imperial College and honorary consultant physician at the Royal Brompton Hospital London. He is one of the most highly cited scientists in the world

(See a Problem?)

Peter Barnes 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) (12905)
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. (1997) (4674)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017) (3143)
Global strategy for asthma management and prevention: GINA executive summary (2008) (2982)
Chronic obstructive pulmonary disease. (2000) (2258)
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response (2000) (1869)
Systemic manifestations and comorbidities of COPD (2009) (1561)
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. (1997) (1536)
Anti-inflammatory actions of glucocorticoids: molecular mechanisms. (1998) (1505)
Increased nitric oxide in exhaled air of asthmatic patients (1994) (1480)
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. (1996) (1458)
Immunology of asthma and chronic obstructive pulmonary disease (2008) (1349)
Exhaled breath condensate: methodological recommendations and unresolved questions (2005) (1229)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (2019) (1127)
Decreased histone deacetylase activity in chronic obstructive pulmonary disease. (2005) (972)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) (946)
Glucocorticoid resistance in inflammatory diseases (2009) (909)
The cytokine network in asthma and chronic obstructive pulmonary disease. (2008) (890)
Neutrophilic inflammation in severe persistent asthma. (1999) (880)
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. (2016) (858)
Exhaled markers of pulmonary disease. (2001) (841)
Inflammatory mediators of asthma: an update. (1998) (799)
Exacerbations of chronic obstructive pulmonary disease (2007) (797)
Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 (2000) (746)
Isoprostanes: markers and mediators of oxidative stress (2004) (730)
Efficacy and safety of inhaled corticosteroids. New developments. (1998) (725)
Anti-inflammatory actions of steroids: molecular mechanisms. (1993) (723)
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. (1998) (716)
Chronic obstructive pulmonary disease in non-smokers (2009) (716)
Mediators of Chronic Obstructive Pulmonary Disease (2004) (700)
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. (1997) (699)
How corticosteroids control inflammation: Quintiles Prize Lecture 2005 (2006) (696)
Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. (2001) (694)
Inhaled glucocorticoids for asthma. (1995) (628)
Neural control of human airways in health and disease. (2015) (623)
Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression (2006) (622)
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. (1996) (595)
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. (1997) (591)
Sex and gender: modifiers of health, disease, and medicine (2020) (589)
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. (2008) (574)
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. (2013) (571)
Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. (2000) (568)
Oxidative stress in COPD. (2013) (559)
In situ hybridization. (1997) (557)
Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. (1999) (556)
Histone acetylation and deacetylation: importance in inflammatory lung diseases (2005) (549)
Reactive oxygen species and airway inflammation. (1990) (530)
Nitric oxide and asthmatic inflammation. (1995) (521)
Nuclear factor-kappa B. (1997) (516)
Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. (2005) (508)
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression (2002) (496)
Efficacy and Safety of Inhaled Corticosteroids in Asthma (1993) (487)
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. (2001) (481)
Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. (2002) (474)
Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages (2004) (473)
New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. (1989) (472)
Acute and chronic effects of cigarette smoking on exhaled nitric oxide. (1995) (472)
Glucocorticosteroids: current and future directions (2011) (471)
Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid (1998) (460)
Beta-adrenergic receptors and their regulation. (1995) (459)
Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. (1998) (453)
A new approach to the treatment of asthma. (1989) (452)
Nitric oxide and lung disease. (1993) (446)
Cytokines in asthma (1999) (438)
Neuropeptides in the respiratory tract. Part I. (1991) (436)
Theophylline: new perspectives for an old drug. (2003) (430)
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. (2009) (424)
Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. (1999) (422)
Changes in sputum eosinophils predict loss of asthma control. (2000) (422)
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. (1997) (420)
Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. (1995) (415)
p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. (2002) (411)
Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. (1980) (411)
Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response (2000) (409)
Inflammatory mediators and asthma. (1988) (405)
COPD as a disease of accelerated lung aging(a). (2009) (400)
Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. (1992) (394)
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase (2004) (390)
Corticosteroid effects on cell signalling (2006) (386)
Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β ☆ (1997) (385)
A European Respiratory Society technical standard: exhaled biomarkers in lung disease (2017) (383)
Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. (1995) (377)
Exhaled nitric oxide in pulmonary diseases: a comprehensive review. (2010) (377)
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma (2018) (373)
Cellular and molecular mechanisms of chronic obstructive pulmonary disease. (2014) (367)
Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. (2004) (365)
New anti-inflammatory targets for chronic obstructive pulmonary disease (2013) (361)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary (2017) (360)
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. (1999) (359)
Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD (2002) (358)
Regulation of pulmonary vascular tone. (1995) (357)
Measurement of exhaled nitric oxide in children, 2001 (2002) (357)
Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. (1998) (349)
Expression of inducible nitric oxide in human lung epithelial cells. (1994) (349)
Positional cloning of a novel gene influencing asthma from Chromosome 2q14 (2003) (342)
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. (2004) (341)
How Do Corticosteroids Work in Asthma? (2003) (336)
Transcription factors and asthma. (1998) (336)
The cytokine network in chronic obstructive pulmonary disease. (2009) (335)
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. (2003) (335)
Mechanisms in COPD: differences from asthma. (2000) (332)
Induction of cyclo‐oxygenase‐2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone (1994) (331)
Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. (2007) (330)
Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma (1992) (330)
Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. (1995) (326)
Elevated levels of exhaled nitric oxide in bronchiectasis. (1995) (325)
Alveolar Macrophages as Orchestrators of COPD (2004) (322)
Exhaled nitric oxide in chronic obstructive pulmonary disease. (1998) (318)
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. (1985) (317)
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children (2003) (315)
Defective macrophage phagocytosis of bacteria in COPD (2009) (315)
As‐Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma (2018) (310)
Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. (2010) (309)
Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress (1998) (308)
Chronic obstructive pulmonary disease (2012) (302)
Expression and activity of histone deacetylases in human asthmatic airways. (2002) (302)
Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease (2015) (299)
Neurogenic inflammation in the airways. (2001) (297)
Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. (1996) (296)
Importance of inhaler devices in the management of airway disease. (2008) (294)
Pulmonary biomarkers in chronic obstructive pulmonary disease. (2006) (294)
8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. (2003) (293)
Haplotype associated with low interleukin-10 production in patients with severe asthma (1998) (292)
Airway inflammation after controlled exposure to diesel exhaust particulates. (2000) (290)
Role of HDAC2 in the pathophysiology of COPD. (2009) (289)
Exhaled leukotrienes and prostaglandins in COPD (2003) (287)
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD (2003) (287)
Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. (2000) (286)
EFFECT OF A GINKGOLIDE MIXTURE (BN 52063) IN ANTAGONISING SKIN AND PLATELET RESPONSES TO PLATELET ACTIVATING FACTOR IN MAN (1987) (285)
Systematic assessment of difficult-to-treat asthma (2003) (283)
Mechanisms and resistance in glucocorticoid control of inflammation (2010) (282)
The effect of airway epithelium on smooth muscle contractility in bovine trachea (1985) (281)
New concepts in chronic obstructive pulmonary disease. (2003) (280)
Cellular and molecular mechanisms of asthma and COPD. (2017) (280)
Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. (2006) (279)
Biomarkers of some pulmonary diseases in exhaled breath (2002) (278)
Corticosteroids: the drugs to beat. (2006) (277)
Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. (2002) (276)
The costs of asthma. (1996) (275)
Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma (1999) (275)
Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. (1997) (274)
Exhaled nitric oxide: a new lung function test. (1996) (273)
The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. (2006) (272)
Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough (1996) (271)
Nitric oxide and airway disease. (1995) (268)
Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. (1997) (265)
Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. (1995) (265)
Increased nitrotyrosine in exhaled breath condensate of patients with asthma. (2000) (264)
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. (2002) (263)
Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. (1995) (263)
Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. (1998) (263)
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma (2008) (263)
8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. (1998) (260)
Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. (2000) (260)
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. (1997) (260)
Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. (1996) (259)
Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. (1995) (257)
Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma (1995) (254)
Oxidative Stress Induces NFκB DNA Binding and Inducible NOS mRNA in Human Epithelial Cells (1994) (253)
Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. (2003) (252)
Accelerated ageing of the lung in COPD: new concepts (2015) (250)
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease (2018) (248)
Bradykinin-induced bronchoconstriction in humans. Mode of action. (1987) (247)
Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. (2004) (247)
The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-α in Asthma (2006) (247)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial (2021) (246)
COPD: current therapeutic interventions and future approaches (2005) (246)
Clinical aspects of exhaled nitric oxide. (2000) (244)
Theophylline in the management of asthma: time for reappraisal? (1994) (242)
Therapeutic strategies for allergic diseases (1999) (240)
Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma (2002) (240)
Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. (1999) (240)
COPD as a disease of accelerated lung aging. (2009) (239)
Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. (1990) (237)
Bronchoconstrictor response to inhaled capsaicin in humans. (1985) (237)
Molecular mechanisms of corticosteroid resistance. (2008) (236)
Exhaled leukotrienes and prostaglandins in asthma. (2002) (234)
Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T‐lymphocytes: role in regulating proliferation and the biosynthesis of interleukin‐2 (1996) (233)
Autonomic regulation of the airways. (1984) (232)
Insights into oxidative stress: the isoprostanes. (2007) (231)
Modulation of neurotransmission in airways. (1992) (231)
Efficacy of inhaled corticosteroids in asthma. (1998) (229)
Exhaled biomarkers. (2006) (223)
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. (2012) (223)
Platelet-activating factor as a mediator of allergic disease. (1988) (223)
Chronic idiopathic cough: a discrete clinical entity? (2005) (222)
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights (2011) (222)
Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. (2009) (219)
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. (2003) (218)
Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. (2005) (217)
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis (2000) (216)
The pharmacological properties of tiotropium. (2000) (214)
Increased leukotrienes in exhaled breath condensate in childhood asthma. (2002) (214)
Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. (2001) (213)
Is exposure to biomass smoke the biggest risk factor for COPD globally? (2010) (213)
Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. (1995) (211)
Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD (2003) (211)
Elevation of exhaled ethane concentration in asthma. (2000) (211)
Repression of Cyclooxygenase-2 and Prostaglandin E2Release by Dexamethasone Occurs by Transcriptional and Post-transcriptional Mechanisms Involving Loss of Polyadenylated mRNA* (1998) (210)
Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. (1995) (209)
Exhaled nitric oxide from lung periphery is increased in COPD (2005) (209)
Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. (1988) (208)
Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. (2004) (206)
New therapies for asthma: is there any progress? (2010) (205)
Cytokines as mediators of chronic asthma. (1994) (204)
NF-kB: a pivotal role in asthma and a new target for therapy (1997) (203)
Stimulation of degranulation from human eosinophils by platelet-activating factor. (1989) (203)
A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. (1989) (202)
Th2 cytokines and asthma: an introduction (2001) (198)
New drugs for asthma (1992) (198)
Modulation of neurogenic inflammation: novel approaches to inflammatory disease. (1990) (197)
Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs (2010) (197)
Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. (1987) (197)
Pathophysiology of asthma. (2003) (195)
Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. (2002) (194)
Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. (1997) (193)
Asthma : basic mechanisms and clinical management (1988) (192)
New molecular targets for the treatment of neutrophilic diseases. (2007) (192)
Prospects for new drugs for chronic obstructive pulmonary disease (2004) (192)
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. (2010) (192)
An in vitro study of the properties of single vagal afferents innervating guinea‐pig airways. (1993) (190)
Analysis of expired air for oxidation products. (2002) (189)
Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. (1991) (189)
Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. (2002) (189)
IκBα Degradation and Nuclear Factor-κB DNA Binding Are Insufficient for Interleukin-1β and Tumor Necrosis Factor-α-induced κB-dependent Transcription* (1998) (189)
Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. (1998) (186)
Treatment of airway mucus hypersecretion (2006) (185)
Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type (1997) (184)
Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress (2011) (183)
Analysis of exhaled breath condensate for monitoring airway inflammation. (2002) (181)
Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. (1989) (181)
Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma. (1996) (180)
TGFβ1 allele association with asthma severity (2001) (180)
Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2 (2004) (180)
Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription. (1999) (177)
Exhaled carbon monoxide and nitric oxide in COPD. (2001) (176)
Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. (2019) (175)
Delayed eosinophil apoptosis in asthma. (2000) (174)
Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines. (1997) (173)
Severe asthma: advances in current management and future therapy. (2012) (171)
Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma (1980) (171)
Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. (1996) (170)
Defective phagocytosis in airways disease. (2012) (169)
Distribution of receptor targets in the lung. (2004) (169)
Glucocorticoids: effects on gene transcription. (2004) (167)
High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. (2003) (166)
Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. (1997) (166)
VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. (1986) (165)
Maternally imprinted microRNAs are differentially expressed during mouse and human lung development (2007) (165)
Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. (2002) (165)
Glucocorticoid receptor localization in normal and asthmatic lung. (1996) (165)
Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. (2010) (164)
SEVERE PREMENSTRUAL EXACERBATIONS OF ASTHMA: EFFECT OF INTRAMUSCULAR PROGESTERONE (1988) (163)
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress (1998) (163)
Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. (2001) (163)
Expression of RANTES mRNA and protein in airways of patients with mild asthma. (1996) (163)
L-arginine increases exhaled nitric oxide in normal human subjects. (1995) (163)
Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids (1998) (162)
Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. (2002) (162)
Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. (2012) (161)
The Electronic Nose in Respiratory Medicine (2012) (160)
Senescence in COPD and Its Comorbidities. (2017) (160)
Reduced histone deacetylase in COPD: clinical implications. (2006) (159)
Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. (1995) (159)
Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. (1993) (158)
Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized brown-Norway rats. (1991) (157)
Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. (1993) (157)
Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. (1996) (157)
Air pollution and asthma. (1994) (157)
Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia (2003) (156)
Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. (2000) (155)
CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. (2008) (155)
Integrated care pathways for airway diseases (AIRWAYS-ICPs) (2014) (155)
Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. (2002) (155)
Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. (1995) (154)
Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. (2009) (154)
Inhaled Corticosteroids (2010) (153)
Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+ T-Lymphocytes (2004) (153)
Glucocorticoid resistance in asthma. (1995) (152)
New treatments for copd (2002) (152)
Regulation of Th2 Cytokine Genes by p38 MAPK-Mediated Phosphorylation of GATA-31 (2007) (151)
SINGLE-DOSE SLOW-RELEASE AMINOPHYLLINE AT NIGHT PREVENTS NOCTURNAL ASTHMA (1982) (151)
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer (2011) (151)
Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. (2003) (151)
Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. (2015) (150)
A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients. (1999) (150)
Epigenetics and airways disease (2006) (150)
Mechanisms of action of glucocorticoids in asthma. (1996) (149)
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. (1995) (149)
Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. (2005) (149)
Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. (1997) (148)
p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids (2001) (148)
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. (2006) (147)
Muscarinic receptor subtypes in airways. (1993) (147)
NF-κB and Activator Protein 1 Response Elements and the Role of Histone Modifications in IL-1β-Induced TGF-β1 Gene Transcription1 (2006) (147)
Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways. (1991) (147)
Effect of corticosteroids on airway hyperresponsiveness. (1990) (147)
Scientific rationale for using a single inhaler for asthma control (2007) (145)
Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic (2007) (145)
Elevated levels of expired breath hydrogen peroxide in bronchiectasis. (1998) (145)
Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. (1998) (145)
Autoradiographic localization of autonomic receptors in airway smooth muscle. Marked differences between large and small airways. (1983) (145)
Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. (1992) (145)
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial (2001) (144)
Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone (1997) (144)
Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke (2001) (144)
Increased exhaled 8-isoprostane in childhood asthma. (2003) (144)
Oxidative stress-based therapeutics in COPD (2020) (144)
A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. (1993) (144)
Role of potassium channels in bronchodilator responses in human airways. (1992) (143)
Muscarinic receptor subtypes in airways. (1993) (143)
Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors (1991) (142)
Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. (1996) (142)
Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma (2000) (142)
Mechanisms of development of multimorbidity in the elderly (2015) (142)
Theophylline in chronic obstructive pulmonary disease: new horizons. (2005) (141)
NO or no NO in asthma? (1996) (141)
Inhaled corticosteroids in COPD: the case against (2009) (140)
Molecular mechanisms and cellular effects of glucocorticosteroids. (2005) (140)
Burden and pathogenesis of chronic obstructive pulmonary disease. (2009) (140)
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD (2009) (140)
Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. (2008) (139)
Pharmacology of airway smooth muscle. (1998) (139)
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis (2011) (139)
Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis (2014) (138)
Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. (2009) (138)
Autoradiographic mapping of substance P receptors in lung. (1986) (138)
The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. (2006) (138)
Circulating catecholamines in exercise and hyperventilation induced asthma. (1981) (137)
Inhibition of cholinergic neurotransmission in human airways by beta 2-adrenoceptors. (1988) (137)
The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. (1992) (137)
Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. (1995) (136)
Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? (2004) (136)
Small airways in COPD. (2004) (136)
The Role of Oxidative Stress in Chronic Obstructive Pulmonary Disease (2004) (136)
Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. (2004) (136)
Dysfunction of Endothelial Progenitor Cells from Smokers and Chronic Obstructive Pulmonary Disease Patients Due to Increased DNA Damage and Senescence (2013) (136)
Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. (2011) (135)
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. (1999) (135)
Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. (1997) (135)
A calcium antagonist, nifedipine, modifies exercise-induced asthma. (1981) (134)
Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. (1989) (133)
Calcitonin gene‐related peptide is localised to human airway nerves and potently constricts human airway smooth muscle (1987) (132)
Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea‐pigs (1988) (132)
Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases (2005) (132)
Corticosteroid resistance in airway disease. (2004) (131)
Effects of capsazepine against capsaicin- and proton-evoked excitation of single airway C-fibres and vagus nerve from the guinea-pig (1995) (131)
The effect of oxidative stress on histone acetylation and IL-8 release. (2003) (131)
Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. (1992) (131)
Retail sales of inhalation devices in European countries: so much for a global policy. (2011) (131)
Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects (1999) (130)
Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. (2006) (130)
The role of anticholinergics in chronic obstructive pulmonary disease. (2004) (130)
Effect of β agonists on inflammatory cells (1999) (129)
8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. (1996) (129)
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. (2001) (129)
Emerging pharmacotherapies for COPD. (2008) (128)
An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. (1996) (128)
Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. (1990) (128)
Theobromine inhibits sensory nerve activation and cough (2005) (128)
Localization of muscarinic receptor subtype mRNAs in human lung. (1992) (127)
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation (2004) (127)
Cytokine modulators as novel therapies for asthma. (2002) (127)
Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. (1997) (126)
Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease (2010) (126)
Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects (1998) (126)
Inhaled Corticosteroids in COPD: A Controversy (2010) (125)
Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. (2003) (125)
Effect of repeated sputum induction on cell counts in normal volunteers. (1998) (125)
Adenosine as a Vasodilator in Primary Pulmonary Hypertension (1991) (123)
Biochemical Basis of Asthma Therapy* (2011) (123)
Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea‐pig trachea. (1990) (123)
Ligand‐induced differentiation of glucocorticoid receptor (GR) trans‐repression and transactivation: preferential targetting of NF‐κB and lack of I‐κB involvement (1999) (123)
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. (2006) (123)
Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. (2010) (122)
Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects. (1983) (122)
Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. (1995) (122)
Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats. (1992) (121)
Effects of tachykinins on mucus secretion in human bronchi in vitro. (1989) (121)
Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? (1999) (120)
Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms. (1990) (120)
SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. (1999) (120)
Poorly perceived asthma. (1992) (119)
Pharmacological Characterization of Indacaterol, a Novel Once Daily Inhaled β2 Adrenoceptor Agonist, on Small Airways in Human and Rat Precision-Cut Lung Slices (2008) (119)
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. (1990) (119)
Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. (1995) (119)
Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells (2016) (118)
Inhibitory histamine H3-receptors on cholinergic nerves in human airways. (1989) (118)
Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. (1986) (118)
Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. (2001) (118)
Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. (1997) (117)
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. (1986) (117)
Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. (1999) (116)
Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma. (1992) (116)
Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding. (1997) (116)
Update on asthma. (2003) (116)
Faster rise of exhaled breath temperature in asthma: a novel marker of airway inflammation? (2002) (115)
Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. (1995) (115)
Alternative mechanisms for tiotropium. (2009) (115)
CIGARETTE SMOKE DECREASES INDUCIBLE NITRIC OXIDE SYNTHASE IN LUNG EPITHELIAL CELLS (2003) (115)
Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. (2001) (115)
Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. (2000) (114)
Histone deacetylase-2 and airway disease (2009) (114)
Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generation (1997) (114)
alpha 1-Adrenergic receptors in guinea pig myocardium: identification by binding of a new radioligand, (3H)-prazosin. (1979) (114)
Developmental changes in endothelium‐dependent pulmonary vasodilatation in pigs (1992) (113)
Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study (2009) (113)
Steroid resistance in asthma. (1995) (113)
Asthma-COPD Overlap. (2016) (113)
Cytokine-directed therapies for the treatment of chronic airway diseases. (2003) (113)
Phosphatidylinositol response to cholinergic agonists in airway smooth muscle: relationship to contraction and muscarinic receptor occupancy. (1986) (113)
The role of increased airway microvascular permeability and plasma exudation in asthma. (1990) (111)
Exhaled markers of inflammation (2001) (111)
New drugs for asthma, allergy and COPD (2001) (111)
Ozone induction of cytokine‐induced neutrophil chemoattractant (CINC) and nuclear factor‐κb in rat lung: inhibition by corticosteroids (1996) (110)
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. (2006) (110)
Superinduction of COX‐2 mRNA by cycloheximide and interleukin‐1β involves increased transcription and correlates with increased NF‐κB and JNK activation (1997) (110)
Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. (2006) (110)
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia (2003) (110)
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis (2000) (109)
Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial (2002) (109)
Venous plasma histamine in exercise- and hyperventilation-induced asthma in man. (1981) (109)
Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. (2000) (109)
Inflammatory endotypes in COPD (2019) (108)
Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effect of inhaled corticosteroids. (2000) (108)
Inhibition of neurogenic plasma exudation in guinea‐pig airways by CP‐96,345, a new non‐peptide NK1 receptor antagonist (1992) (107)
Muscarinic receptor subtypes: implications for lung disease. (1989) (107)
Transcription factors in airway diseases (2006) (107)
Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma. (1981) (107)
Exhaled nitric oxide is increased in active fibrosing alveolitis. (1999) (107)
Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. (1997) (107)
Molecular mechanisms of steroid action in asthma. (1996) (107)
Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. (1994) (106)
Restoration of Corticosteroid Sensitivity by p38 Mitogen Activated Protein Kinase Inhibition in Peripheral Blood Mononuclear Cells from Severe Asthma (2012) (106)
Opioid modulation of non‐cholinergic neural bronchoconstriction in guinea‐pig in vivo (1988) (106)
Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. (1997) (106)
Mitochondria, telomeres and cell senescence: Implications for lung ageing and disease. (2017) (106)
Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma. (1993) (105)
Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages (2006) (105)
Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. (2004) (105)
Histamine H3‐receptors inhibit cholinergic neurotransmission in guinea‐pig airways (1989) (105)
Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule IκB Kinase Inhibitors (2007) (104)
Regular inhaled salbutamol and asthma control: the TRUST randomised trial (2000) (104)
Bradykinin and asthma. (1992) (104)
Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients. (1997) (103)
Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs. (1988) (103)
Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. (2000) (103)
Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients (2004) (102)
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. (2009) (102)
A Novel Macrolide Solithromycin Exerts Superior Anti-inflammatory Effect via NF-κB Inhibition (2013) (102)
Theophylline for COPD (2006) (101)
Effect of dexamethasone on interleukin‐1β‐(IL‐1β)‐induced nuclear factor‐κB (NF‐κB) and κB‐dependent transcription in epithelial cells (1998) (101)
An inhaled steroid improves markers of airway inflammation in patients with mild asthma. (1998) (101)
Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. (2001) (101)
The role of pirenzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans. (1989) (101)
Novel approaches and targets for treatment of chronic obstructive pulmonary disease. (1999) (101)
Endothelins and pulmonary diseases. (1994) (100)
Neurogenic inflammation and asthma. (1992) (100)
PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. (1996) (99)
Exhaled carbon monoxide in childhood asthma. (1999) (99)
Neural control of goblet cell secretion in guinea pig airways. (1990) (99)
Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways. (1994) (99)
The third nervous system in the lung: physiology and clinical perspectives. (1984) (99)
Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. (1992) (99)
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD (2013) (98)
The prevalence of small airways disease in adult asthma: A systematic literature review. (2016) (98)
Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. (2010) (98)
Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping. (1994) (98)
Nitric oxide and airways. (1993) (98)
Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic Disease (2009) (98)
Dual action of nitric oxide on airway plasma leakage. (1997) (98)
Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. (1990) (98)
Vasoactive intestinal peptide stimulates tracheal submucosal gland secretion in ferret. (1983) (97)
New drugs for exacerbations of chronic obstructive pulmonary disease (2009) (97)
Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. (1989) (97)
Chronic heart failure in the guinea pig increases cardiac α1- and β-adrenoceptors (1980) (97)
Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. (1999) (97)
Neuropeptides and asthma. (1990) (96)
New directions in allergic diseases: mechanism-based anti-inflammatory therapies. (2000) (96)
Corticosteroid inhibition of airway microvascular leakage. (1991) (96)
Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. (1995) (95)
Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves. (1995) (95)
Calcitonin gene-related peptide vasodilation of human pulmonary vessels. (1989) (95)
Increased carbon monoxide in exhaled air of patients with cystic fibrosis (1999) (95)
Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease (2003) (95)
A Comparison of β-Adrenergic Receptors and In Vitro Relaxant Responses to Isoproterenol in Asthmatic Airway Smooth Muscle (1992) (95)
Effect of hydrogen peroxide on guinea‐pig tracheal smooth muscle in vitro: role of cyclo‐oxygenase and airway epithelium (1989) (95)
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease (2016) (94)
IL‐1β‐dependent activation of NF‐κB mediates PGE2 release via the expression of cyclooxygenase‐2 and microsomal prostaglandin E synthase (2003) (94)
Brd4 Is Essential for IL-1β-Induced Inflammation in Human Airway Epithelial Cells (2014) (94)
The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. (2009) (93)
Inhibition of guinea‐pig and human sensory nerve activity and the cough reflex in guinea‐pigs by cannabinoid (CB2) receptor activation (2003) (93)
Expression of heme oxygenase in human airway epithelial cells. (2001) (93)
Correlation of exhaled breath temperature with bronchial blood flow in asthma (2005) (93)
Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids (1997) (92)
Role of GATA-3 in allergic diseases. (2008) (92)
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD (2009) (92)
Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. (2001) (92)
Pseudo-steroid resistant asthma. (1999) (92)
Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. (2002) (92)
Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. (2000) (92)
Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. (1991) (91)
Cyclic nucleotides and phosphodiesterases and airway function. (1995) (91)
Clinical studies with calcium antagonists in asthma. (1985) (91)
RAPID AND SAFE TERMINATION OF SUPRAVENTRICULAR TACHYCARDIA IN CHILDREN BY ADENOSINE (1987) (91)
Exhaled 8-isoprostane in childhood asthma (2005) (91)
Alveolar macrophages in chronic obstructive pulmonary disease (COPD). (2004) (91)
TGFbeta1 allele association with asthma severity. (2001) (91)
Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. (1999) (91)
Effect of inhaled l-arginine on exhaled nitric oxide in normal and asthmatic subjects (1998) (90)
The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro. (1990) (90)
The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. (1984) (90)
Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. (2003) (90)
Effect of substance P on cardiovascular and respiratory function in subjects. (1987) (89)
Neuroeffector mechanisms: the interface between inflammation and neuronal responses. (1996) (89)
Blunted perception and death from asthma. (1994) (89)
New drugs for asthma. (1996) (88)
Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. (2006) (88)
Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe. (1990) (88)
Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. (1994) (88)
Beta2-Adrenergic Receptors on Eosinophils: Binding and Functional Studies (1990) (88)
Small airways: an important but neglected target in the treatment of obstructive airway diseases. (2008) (88)
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial (2008) (88)
The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL‐1β‐dependent PGE2 release via mechanistically distinct processes (2000) (88)
Sex Differences in Chronic Obstructive Pulmonary Disease Mechanisms. (2016) (88)
Neuropeptides in human airways: function and clinical implications. (1987) (87)
Superinduction of NF-kappa B by actinomycin D and cycloheximide in epithelial cells. (1996) (87)
Impaired macrophage phagocytosis of bacteria in severe asthma (2014) (87)
Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats (1999) (87)
Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. (2007) (87)
Anticholinergic blockade of beta-blocker-induced bronchoconstriction. (1989) (87)
Nitric oxide as a neurotransmitter in human airways. (1995) (87)
Potassium channels and airway function: new therapeutic prospects. (1990) (87)
Facilitation by tachykinins of neurotransmission in guinea‐pig pulmonary parasympathetic nerves (1989) (87)
Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. (1998) (87)
Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice (2000) (86)
Molecular genetics of chronic obstructive pulmonary disease (1999) (86)
Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways. (1991) (86)
Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. (1992) (85)
μ-opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways (1987) (85)
The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. (1994) (85)
Histamine and serotonin. (2001) (85)
The airway vasculature: recent advances and clinical implications (2009) (85)
Drugs for asthma (2006) (85)
The action of a potassium channel activator, BRL 38227 (lemakalim), on human airway smooth muscle. (1990) (84)
Probiotics in the Management of Lung Diseases (2013) (84)
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation. (2013) (84)
Barriers to new drug development in respiratory disease (2015) (84)
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study (2017) (84)
New therapies for chronic obstructive pulmonary disease. (1998) (84)
A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways. (1990) (84)
Platelet-activating factor and asthma. (1988) (84)
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease (2005) (84)
Inhibitors of Protein Kinase C (PKC) Prevent Activated Transcription (2004) (83)
Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1beta in vivo in the rat. (1996) (83)
Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol. (1994) (83)
Circadian variation in airway function. (1985) (83)
Reduction of nocturnal asthma by an inhaled anticholinergic drug. (1986) (83)
Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung (2002) (83)
Formoterol attenuates neutrophilic airway inflammation in asthma. (2005) (82)
Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma (2011) (82)
Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine. (2009) (82)
Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. (2001) (82)
Passive Smoking Impairs Histone Deacetylase-2 in Children With Severe Asthma (2013) (82)
Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease (2012) (82)
Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. (2005) (81)
Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis. (2008) (81)
Characterization of T Lymphocytes in Chronic Obstructive Pulmonary Disease (2004) (81)
Naloxone‐insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by the novel opioid, nociceptin (1997) (80)
Future treatments for chronic obstructive pulmonary disease and its comorbidities. (2008) (80)
Exhaled nitric oxide is increased in asthma. (1995) (80)
Exhaled Nitric Oxide and Hydrogen Peroxide Concentrations in Asthmatic Smokers (2004) (80)
Post-Transcriptional Regulation of Bradykinin B1 and B2 Receptor Gene Expression in Human Lung Fibroblasts by Tumor Necrosis Factor-α: Modulation by Dexamethasone (2000) (80)
Determination of mass changes in phosphatidylinositol 4,5-bisphosphate and evidence for agonist-stimulated metabolism of inositol 1,4,5-trisphosphate in airway smooth muscle. (1991) (79)
Histamine H3-receptors modulate nonadrenergic noncholinergic neural bronchoconstriction in guinea-pig in vivo. (1989) (79)
Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. (2008) (79)
p38 MAP kinase and MKK‐1 co‐operate in the generation of GM‐CSF from LPS‐stimulated human monocytes by an NF‐κB‐independent mechanism (2000) (79)
Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. (1995) (79)
NF-kappa B: a pivotal role in asthma and a new target for therapy. (1997) (79)
Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. (2007) (78)
Neurogenic plasma extravasation: inhibition by morphine in guinea pig airways in vivo. (1989) (78)
Acidic mammalian chitinase--a potential target for asthma therapy. (2004) (78)
Circulatory and respiratory effects of infused adenosine in conscious man. (1987) (78)
Interactions of glucocorticoids and beta 2-agonists. (1996) (77)
Effect of theophylline and adenosine on eosinophil function. (1989) (77)
Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium. (1983) (77)
Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children (2005) (77)
Validation of the Anti-Inflammatory Properties of Small-Molecule IκB Kinase (IKK)-2 Inhibitors by Comparison with Adenoviral-Mediated Delivery of Dominant-Negative IKK1 and IKK2 in Human Airways Smooth Muscle (2006) (77)
Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neurotransmission in guinea-pig trachea. (1993) (77)
New Therapies for Asthma and Chronic Obstructive Pulmonary Disease (2017) (77)
Defective bacterial phagocytosis is associated with dysfunctional mitochondria in COPD macrophages (2019) (77)
Nortriptyline Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ (2011) (77)
Chronobiology and asthma. I. Day-night differences in bronchial patency and dyspnea and circadian rhythm dependencies. (1986) (76)
Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. (1988) (76)
Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. (1990) (76)
Neural mechanisms in asthma. (1992) (76)
NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. (2006) (76)
Effect of antiasthma drugs on microvascular leakage in guinea pig airways. (1989) (76)
Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma. (2005) (75)
Muscarinic receptor subtypes insubtypes in Airways (1988) (75)
Comparison of lung vascular and epithelial permeability indices in the adult respiratory distress syndrome. (2015) (75)
Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils. (1989) (75)
No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. (2000) (75)
Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea‐pig airways (1999) (74)
Mass changes of inositol(1,4,5)trisphosphate in trachealis muscle following agonist stimulation. (1989) (74)
Chairman's Summary (1990) (74)
Pathophysiology and clinical presentations of cough. (1996) (74)
Effect of CP-96,345, a non-peptide NK1 receptor antagonist, against substance P-, bradykinin- and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig. (1993) (74)
Glucocorticoids reverse IL‐1β‐induced impairment of β‐adrenoceptor‐mediated relaxation and up‐regulation of G‐protein‐coupled receptor kinases (2002) (73)
Autoradiographic localization of calcitonin gene-related peptide (CGRP) binding sites in human and guinea pig lung (1988) (73)
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) (2016) (73)
ERS/ATS workshop report on respiratory health effects of household air pollution (2018) (73)
Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. (2007) (73)
Cholinergic control of airway smooth muscle. (1987) (73)
Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. (1993) (73)
Chronic obstructive pulmonary disease • 12: New treatments for COPD (2003) (73)
Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+) (2003) (73)
Eotaxin receptor (CCR3) antagonism in asthma and allergic disease. (2002) (72)
Airway responsiveness and inflammation in adolescent elite swimmers. (2008) (72)
Human lung adrenoreceptors studied by radioligand binding. (1980) (72)
Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. (2005) (72)
Modulation of non‐adrenergic, non‐cholinergic neural bronchoconstriction in guinea‐pig airways via GABAB‐receptors (1989) (72)
Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. (1995) (71)
Muscarinic receptors in airways: recent developments. (1990) (71)
New Therapies for Chronic Obstructive Pulmonary Disease (2010) (71)
Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin. (2016) (71)
Current therapies for asthma. Promise and limitations. (1997) (71)
Effect of arginine on mucociliary function in primary ciliary dyskinesia (1998) (71)
The effect of alcohol ingestion on exhaled nitric oxide. (1996) (70)
Molecular regulation of granulocyte macrophage colony-stimulating factor in human lung epithelial cells by interleukin (IL)-1beta, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanisms. (2000) (70)
Stimulation of guinea‐pig tracheal afferent fibres by non‐isosmotic and low‐chloride stimuli and the effect of frusemide. (1995) (70)
IL-1β and TNF-α Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-κB Binding to the Proximal Promoter1 (2006) (70)
T-cells subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure. (1995) (70)
Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. (2002) (69)
Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. (1995) (69)
Effect of inhaled corticosteroids on bones and growth. (1998) (69)
Comparison of neurokinin A and substance P on cardiovascular and airway function in man. (1988) (69)
Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo. (1988) (69)
Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. (2000) (69)
Klotho expression is reduced in COPD airway epithelial cells: effects on inflammation and oxidant injury (2015) (69)
Cytokine-directed therapies for asthma. (2001) (69)
Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. (1991) (69)
Histamine H3-receptors inhibit neurogenic microvascular leakage in airways. (1990) (69)
Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate. (1996) (69)
Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD (2016) (69)
Pulmonary endothelium-derived relaxing factor is impaired in hypoxia. (1989) (69)
Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. (2008) (68)
Adenosine 3′,5′-Cyclic Monophosphate (cAMP)-Dependent Inhibition of IL-5 from Human T Lymphocytes Is Not Mediated by the cAMP-Dependent Protein Kinase A1 (2001) (68)
Localization of beta 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. (1991) (68)
Lipids in cereal technology (1983) (67)
Validation of leukotriene B4 measurements in exhaled breath condensate (2003) (67)
Muscarinic receptors in lung and trachea: autoradiographic localization using [3H]quinuclidinyl benzilate. (1982) (67)
Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD (2005) (67)
Autoradiographic visualization of bradykinin receptors in human and guinea pig lung. (1991) (67)
Eosinophils adhere to and stimulate replication of lung fibroblasts ‘in vitro’ (1991) (67)
Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. (1987) (67)
COPD—a neglected disease (2004) (66)
A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals. (1980) (66)
Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. (1996) (66)
"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. (2001) (66)
PRODUCTION OF 6-OXO-PGF1α BY HUMAN LUNG IN VIVO (1979) (65)
Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. (2004) (65)
Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage (2008) (65)
Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. (1988) (65)
Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. (1995) (65)
Role of nitric oxide and guanosine 3′,5′‐cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea‐pig pulmonary arteries (1992) (65)
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages (2017) (65)
cAMP immunocytochemistry provides evidence for functional VIP receptors in trachea. (1986) (65)
Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness. (1990) (65)
Inhaled Corticosteroids Reduce Bone Mineral Density in Early Postmenopausal but Not Premenopausal Asthmatic Women (2001) (65)
Circulating catecholamines in acute asthma. (1985) (65)
Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells. (1993) (65)
Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor. (1990) (64)
Albuterol-induced downregulation of Gsα accounts for pulmonary β2-adrenoceptor desensitization in vivo (2000) (64)
Airway hyperresponsiveness is associated with inflammatory cell infiltration in allergic brown-Norway rats. (1992) (64)
Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. (1997) (64)
A comprehensive analysis of oxidative stress in the ozone-induced lung inflammation mouse model. (2014) (64)
Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. (1994) (64)
Platelet activating factor and human disease (1989) (64)
Nocturnal asthma: mechanisms and treatment. (1984) (64)
Questions about inhaled β2-adrenoceptor agonists in asthma (1992) (64)
Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea. (1995) (63)
Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease (2014) (63)
Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung (1997) (63)
Alternate COX-2 transcripts are differentially regulated: implications for post-transcriptional control. (1997) (63)
Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist (2013) (63)
Novel signal transduction modulators for the treatment of airway diseases. (2006) (63)
Demonstration of α1-adrenoceptors in guinea pig lung using 3H-prazosin (1979) (62)
Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells. (2011) (62)
Corticosteroids, IgE, and atopy. (2001) (62)
Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man. (1988) (62)
Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma. (1989) (62)
HISTAMINE INCREASES LUNG PERMEABILITY BY AN H2-RECEPTOR MECHANISM (1984) (62)
Attenuated production of intracellular IL-10 and IL-12 in monocytes from patients with severe asthma. (2002) (62)
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. (2006) (61)
Anti-inflammatory mechanisms of glucocorticoids. (1995) (61)
Is immunotherapy for asthma worthwhile? (1996) (61)
Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry (2013) (61)
p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β2 Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma (2011) (61)
Chronic obstructive pulmonary disease: new opportunities for drug development. (1998) (61)
Effect of interleukin-1β on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats (1994) (61)
Endogenous tachykinins facilitate transmission through parasympathetic ganglia in guinea‐pig trachea (1993) (61)
Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. (2002) (61)
Cytokine modulators as novel therapies for airway disease (2001) (60)
Radioligand binding of antagonists of platelet‐activating factor to intact human platelets (1988) (60)
Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig. (1989) (60)
Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease (2018) (60)
Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. (1988) (60)
Anti-inflammatory therapy for asthma. (1993) (60)
CCL11 as a potential diagnostic marker for asthma? (2014) (60)
Insulin-like growth factor I is a major fibroblast mitogen produced by primary cultures of human airway epithelial cells. (1995) (60)
Microarray analysis of long non-coding RNAs in COPD lung tissue (2014) (60)
Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. (1995) (59)
Plasma histamine and catecholamines in stable asthmatic subjects. (1982) (59)
Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study (2006) (59)
Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5. (2003) (59)
Inflammation, Oxidative Stress and Systemic Effects in Mild Chronic Obstructive Pulmonary Disease (2007) (59)
Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea‐pigs in vivo (1993) (59)
Orientation to Visual Stimuli and the Superior Colliculus in the Rat (1970) (59)
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review (2004) (58)
New perspectives in pharmacological treatment of mild persistent asthma. (2011) (58)
Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219. (1993) (58)
Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′-monophosphate in asthma (1998) (58)
Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. (1981) (58)
Difficult asthma. (1989) (57)
Inhibition of cholinergic neurotransmission in human airways by opioids. (1992) (57)
Nonadrenergic, noncholinergic airway inhibitory nerves. (1992) (57)
Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. (1989) (57)
Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. (2002) (57)
IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. (2003) (56)
Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs. (1994) (56)
Neurogenic Inflammation in Airways (1991) (56)
Modulation of airway smooth muscle beta-adrenoceptor function by a muscarinic agonist. (1994) (56)
Hyperventilation-induced asthma: evidence for two mechanisms. (1982) (56)
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial (2018) (56)
Proliferation of airway epithelium after ozone exposure: effect of apocynin and dexamethasone. (1998) (56)
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man (1980) (56)
The role of inflammation and anti-inflammatory medication in asthma. (2002) (56)
Circadian variation in adrenergic responses in asthmatic subjects. (1982) (56)
‘Outside‐in’ signalling mechanisms underlying CD11b/CD18‐mediated NADPH oxidase activation in human adherent blood eosinophils (1999) (56)
Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences (1994) (55)
Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. (1998) (55)
Bradykinin‐induced plasma exudation in guinea‐pig airways: involvement of platelet activating factor (1990) (55)
Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients. (2005) (55)
Epidemiology, Risk Factors and Pathophysiology (2011) (55)
Synergy between tumor necrosis factor alpha and interleukin 1beta in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression. Involvement of protein kinase A and ceramide pathways. (1996) (55)
Endogenous catecholamines and asthma. (1986) (55)
Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. (1994) (55)
Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. (2003) (55)
Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects. (1988) (55)
Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. (2002) (55)
Exhaled carbon monoxide in patients with lower respiratory tract infection. (2001) (54)
Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients. (2009) (54)
Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis (1998) (54)
Does exhaled nitric oxide reflect asthma control? Yes, it does! (2001) (54)
Exhaled carbon monoxide in asthmatics: a meta-analysis (2010) (54)
Hypoxia-inducible Factor 1α Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription* (2009) (54)
Disease Markers in Exhaled Breath (2002) (54)
Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol. (1993) (54)
Muscarinic receptor subtypes in human and guinea pig lung. (1989) (53)
Contrasting effects of prostaglandins E2 and F2 alpha on sensitivity of the human cough reflex. (1992) (53)
Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils. (1993) (53)
Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD (2015) (53)
Effect of beta-agonists on inflammatory cells. (1999) (53)
Characterization of beta adrenoceptor subtypes in canine airway smooth muscle by radioligand binding and physiological responses. (1983) (52)
Effects of dexamethasone on cytokine and phorbol ester stimulated c-Fos and c-Jun DNA binding and gene expression in human lung. (1994) (52)
Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. (2008) (52)
A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist. (2007) (52)
Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea‐pig airways in vivo and in vitro (1992) (52)
Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans. (1981) (52)
Autoradiographic mapping of beta-adrenoceptors in human skin (1996) (52)
Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease. (2014) (52)
Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram, Salbutamol, and Prostaglandin E2: A Comparison with H-89 (2004) (52)
Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD (2016) (52)
The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge. (2011) (51)
Reduced intracellular magnesium concentrations in asthmatic patients. (1999) (51)
Neuropeptides in the respiratory tract. Part II. (1991) (51)
Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial. (2016) (51)
Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole. (1987) (51)
Characterization of platelet‐activating factor‐induced elevation of cytosolic free calcium concentration in eosinophils (1989) (51)
Frontiers in medicine: New aspects of asthma (1992) (51)
Editorial: Special Issue (1987) (51)
Is asthma a nervous disease? The Parker B. Francis Lectureship. (1995) (51)
Calcium-channel blockers and asthma. (1983) (50)
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression (2017) (50)
Early signalling events implicated in leukotriene B4-induced activation of the NADPH oxidase in eosinophils: role of Ca2+, protein kinase C and phospholipases C and D. (1995) (50)
Localization of neutral endopeptidase (NEP) mRNA in human bronchi. (1995) (50)
ICAM‐1 expression is highly NF‐κB‐dependent in A549 cells (2004) (50)
Inhibitory cytokines in asthma. (1998) (50)
‘Sensory‐efferent’ neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro (1994) (50)
IL-1 beta and TNF-alpha regulation of the adenosine receptor (A2A) expression: differential requirement for NF-kappa B binding to the proximal promoter. (2006) (50)
Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins. (1990) (50)
Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. (2004) (50)
Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro. (1991) (49)
Effect of infused adenosine on cardiac output and systemic resistance in normal subjects. (1989) (49)
MicroRNA-570 is a novel regulator of cellular senescence and inflammaging (2018) (49)
Perennial rhinitis subjects have altered vascular, glandular, and neural responses to bradykinin nasal provocation. (1994) (49)
Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. (1999) (49)
Statins as potential therapeutic drug for asthma? (2012) (49)
Oxidative stress modulates theophylline effects on steroid responsiveness. (2008) (49)
Effect of tachykinins in small human airways (1991) (49)
Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. (1994) (49)
Caspase-catalyzed cleavage and activation of Mst1 correlates with eosinophil but not neutrophil apoptosis. (2002) (49)
Expression of inducible nitric oxide synthase mRNA in Brown Norway rats exposed to ozone: effect of dexamethasone. (1995) (49)
Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium Report of a workshop held in Whistler, British Columbia, Canada, 18–19 May 1995 (1995) (49)
Future Advances in COPD Therapy (2001) (49)
Glucocorticoids Preferentially Increase Fetal Alveolar β-Adrenoreceptors: Autoradiographic Evidence (1984) (49)
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study. (2001) (49)
Airflow obstruction after substance P aerosol: contribution of airway and pulmonary edema. (1990) (48)
Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodelling in chronic obstructive pulmonary disease. (2017) (48)
Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages. (1995) (48)
Capsaicin-induced bronchodilation in mild asthmatic subjects: possible role of nonadrenergic inhibitory system. (1989) (48)
Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. (1998) (48)
Capsazepine as a selective antagonist of capsaicin-induced activation of C-fibres in guinea-pig bronchi. (1992) (48)
Chronic obstructive pulmonary disease and lung cancer: a lethal association. (2011) (48)
Toll-like receptor 3 stimulation causes corticosteroid-refractory airway neutrophilia and hyperresponsiveness in mice. (2013) (48)
Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by isoprenaline (1996) (48)
Small airway fibrosis in COPD. (2019) (48)
Bromodomain and Extraterminal Proteins Suppress NF-E2–Related Factor 2–Mediated Antioxidant Gene Expression (2014) (48)
Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment (2005) (47)
Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. (1993) (47)
Evidence that the anti‐spasmogenic effect of the β‐adrenoceptor agonist, isoprenaline, on guinea‐pig trachealis is not mediated by cyclic AMP‐dependent protein kinase (2001) (47)
Identification of the protein kinase C isoenzymes in human lung and airways smooth muscle at the protein and mRNA level. (1997) (47)
Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy (2017) (47)
Nitric oxide in exhaled air is a new marker of airway inflammation. (1996) (47)
The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. (1987) (47)
Regulation of IL-17 in chronic inflammation in the human lung. (2011) (47)
Differential down-regulation of pulmonary β1- and β2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline (1993) (47)
Effects of prolonged repeated exposure to ovalbumin in sensitized brown Norway rats. (1994) (47)
Regulation of NANC neural bronchoconstriction in vivo in the guinea‐pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase (1993) (47)
Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography (1986) (47)
Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? (2003) (46)
Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. (1994) (46)
Neuropeptide Y is a vasoconstrictor in human nasal mucosa. (1992) (46)
Tumour Necrosis Factor-α Regulates Human Eosinophil Apoptosis via Ligation of TNF-Receptor 1 and Balance between NF-κB and AP-1 (2014) (46)
IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway. (1998) (46)
Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease. (2004) (46)
Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor. (1989) (46)
Formation of inositol polyphosphates in airway smooth muscle after muscarinic receptor stimulation. (1990) (46)
Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release. (2004) (46)
A thromboxane mimetic, U-46619, produces plasma exudation in airways of the guinea pig. (1992) (46)
Prazosin, an alpha1-adrenoceptor antagonist, partially inhibits exercise-induced asthma (1981) (46)
Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD (2016) (46)
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD. (2013) (46)
Single dose topical corticosteroid inhibits IL‐5 and IL‐13 in nasal lavage following grass pollen challenge (2005) (45)
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists (2018) (45)
Receptor heterodimerization: a new level of cross-talk. (2006) (45)
IL‐10: a key regulator of allergic disease (2001) (45)
Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma (1999) (45)
PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086. (1989) (45)
Cyclic AMP‐elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM‐CSF (1996) (45)
Local Vasodilator Response to Mobile Phones (2001) (45)
Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers. (2007) (45)
Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. (2004) (44)
Mapping of adrenergic receptors in the trachea by autoradiography. (1983) (44)
Inflammatory mediator receptors and asthma. (1987) (44)
Molecular mechanisms of glucocorticoid action in asthma. (1997) (44)
Muscarinic receptor subtypes in airways. (1993) (44)
Transcriptional Down-regulation of m2 Muscarinic Receptor Gene Expression in Human Embryonic Lung (HEL 299) Cells by Protein Kinase C (*) (1995) (44)
Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma. (2009) (44)
Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung. (2002) (44)
Up-regulation of airway smooth muscle histamine H(1) receptor mRNA, protein, and function by beta(2)-adrenoceptor activation. (2000) (44)
Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. (1994) (44)
Effect of infused vasoactive intestinal peptide on airway function in normal subjects. (1986) (44)
PAF closely mimics pathology of asthma (1987) (44)
Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells (2015) (43)
Decreased indoleamine 2,3-dioxygenase activity and IL-10/IL-17A ratio in patients with COPD (2012) (43)
The Airways: Neural Control in Health and Disease (1987) (43)
Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man. (1989) (43)
Platelet-activating factor causes ventilation-perfusion mismatch in humans. (1994) (43)
Mitogen-activated protein kinases mediate peroxynitrite-induced cell death in human bronchial epithelial cells. (2003) (43)
Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. (2007) (43)
Inhaled prazosin in asthma. (1981) (43)
Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells. (1998) (43)
Posture and theophylline kinetics. (1985) (43)
Decreased Serum Sirtuin-1 in COPD (2017) (42)
Endogenous inhibitory mechanisms in asthma. (2000) (42)
Contrasting effects of two xanthines, theophylline and enprofylline, on the cardio-respiratory stimulation of infused adenosine in man. (1987) (42)
The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD (2016) (42)
Characterization of agonist-stimulated incorporation of myo-[3H]inositol into inositol phospholipids and [3H]inositol phosphate formation in tracheal smooth muscle. (1989) (42)
Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea‐pig and platelet aggregation in man (1988) (42)
Current and future therapies for airway mucus hypersecretion. (2002) (42)
Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD (2017) (42)
Ozone-induced airway hyperresponsiveness: role of superoxide anions, NEP, and BK receptors. (1995) (42)
Autoradiographic mapping of calcitonin gene-related peptide receptors in human and guinea pig hearts. (1990) (42)
Cigarette smoke-induced airway goblet cell secretion: dose-dependent differential nerve activation. (1992) (42)
COPD: is there light at the end of the tunnel? (2004) (42)
Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage. (1991) (41)
A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma. (2006) (41)
The effect of peptidase inhibitors on bradykinin‐induced bronchoconstriction in guinea‐pigs in vivo (1990) (41)
Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease (2020) (41)
Neurogenic inflammation in airways and its modulation. (1990) (41)
Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. (1988) (41)
Autoradiographic localisation of β-adrenoceptors in human lung (1984) (41)
Frontrunners in novel pharmacotherapy of COPD. (2008) (41)
The effect of sensory nerve depletion on cholinergic neurotransmission in guinea-pig airways. (1989) (41)
Anti-IgE Therapy in Asthma: Rationale and Therapeutic Potential (2000) (41)
Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation. (2012) (41)
Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-alpha: modulation by dexamethasone. (2000) (41)
Platelet-activating factor stimulates a rapid accumulation of inositol (1,4,5)trisphosphate in guinea pig eosinophils: relationship to calcium mobilization and degranulation. (1991) (41)
Role of the mitogen‐activated protein kinases and tyrosine kinases during leukotriene B4‐induced eosinophil activation (1998) (41)
Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig. (1992) (40)
Interleukin 13 inhibits macrophage inflammatory protein-1 alpha production from human alveolar macrophages and monocytes. (1996) (40)
New Drugs: Respiratory and allergic disease—I (1988) (40)
Regulation of muscarinic M2 receptors. (1997) (40)
Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD (2002) (40)
Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. (1997) (40)
Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma (2001) (40)
Contribution of intercellular-adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitised brown-Norway rats. (1994) (40)
Effects of adenosine on autonomic control of heart rate in man. (1987) (40)
The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure (2018) (40)
Sputum myeloperoxidase in chronic obstructive pulmonary disease (2014) (40)
Sputum plasminogen activator inhibitor-1 elevation by oxidative stress-dependent nuclear factor-κB activation in COPD. (2013) (40)
Mechanisms of interleukin 1beta-induced human airway smooth muscle hyporesponsiveness to histamine. Involvement of p38 MAPK NF-kappaB. (2001) (40)
Corticosteroids: still at the frontline in asthma treatment? (2012) (40)
Bronchial hyperreactivity after inhalation of trimellitic anhydride dust in guinea pigs after intradermal sensitization to the free hapten. (1992) (39)
Airway inflammation and autonomic control. (1986) (39)
Muscarinic pharmacology of the airways. (1989) (39)
Cytokine-directed therapy in asthma. (2004) (39)
Increased Vitronectin and Endothelin-1 in the Breath Condensate of Patients with Fibrosing Lung Disease (2003) (39)
The problem of cough and development of novel antitussives. (2007) (39)
Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. (1998) (39)
The Role of IκB Kinase 2, but Not Activation of NF-κB, in the Release of CXCR3 Ligands from IFN-γ-Stimulated Human Bronchial Epithelial Cells (2007) (39)
The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. (1988) (38)
Effect of topical capsaicin on the cutaneous responses to inflammatory mediators and to antigen in man. (1989) (38)
An Atlas of Chronic Obstructive Pulmonary Disease (2003) (38)
Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. (1996) (38)
The size of the problem of managing asthma. (2004) (38)
Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action. (2000) (38)
NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. (1992) (38)
Visualization of muscarinic m4 mRNA and M4 receptor subtype in rabbit lung. (1993) (38)
Asthma guidelines: recommendations versus reality. (2004) (38)
Development of new drugs for COPD. (2013) (37)
Dexamethasone inhibits ozone‐induced gene expression of macrophage inflammatory protein‐2 in rat lung (1995) (37)
Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. (1993) (37)
Evaluation of a breath actuated pressurized aerosol (1976) (37)
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. (1994) (37)
Role of inflammatory mediators in asthma. (1992) (37)
Pleiotropic role of lyn kinase in leukotriene B(4)-induced eosinophil activation. (2000) (37)
Effects of a reversible β‐tryptase and trypsin inhibitor (RWJ‐58643) on nasal allergic responses (2006) (37)
Leukotriene B4 activates the NADPH oxidase in eosinophils by a pertussis toxin-sensitive mechanism that is largely independent of arachidonic acid mobilization. (1998) (37)
Effect of short- and long-acting β2-adrenoceptor agonists on pulmonary β2-adrenoceptor expression in human lung (1996) (37)
Mitochondrial dysfunction in lung ageing and disease (2020) (37)
Efficacy and safety profile of xanthines in COPD: a network meta-analysis (2018) (37)
Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases. (2016) (37)
Characterization of muscarinic receptor subtypes in pig airways: radioligand binding and northern blotting studies. (1994) (37)
Peripheral type benzodiazepine receptors in human and guinea pig lung: characterization and autoradiographic mapping. (1990) (37)
Nebulised adrenaline in acute severe asthma: comparison with salbutamol. (1987) (36)
Achieving asthma control (2005) (36)
Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors. (1996) (36)
Loop diuretics and asthma. (1992) (36)
THE CHRONOPHARMACOLOGY AND CHRONOTHERAPY OF ASTHMA (1986) (36)
5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways. (1995) (36)
Attenuation of inhaled allergen-induced airway microvascular leakage and airflow obstruction in guinea pigs by a 5-lipoxygenase inhibitor (A-63162). (1991) (36)
The changing face of asthma. (1987) (36)
Differential expression of IL‐10 receptor by epithelial cells and alveolar macrophages (2004) (35)
Inflammatory mechanisms and nocturnal asthma. (1988) (35)
Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by interacting with prostanoid receptors of the EP3‐subtype (1998) (35)
Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants. (2008) (35)
Regulation of Wnt4 in chronic obstructive pulmonary disease (2013) (35)
A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients. (2016) (35)
Specific immunological and bronchopulmonary responses following intradermal sensitization to free trimellitic anhydride in guinea pigs (1992) (35)
Ceramide induction of COX-2 and PGE(2) in pulmonary A549 cells does not involve activation of NF-kappaB. (2000) (35)
Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7 (2011) (35)
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages (2001) (35)
Measurement of 8-isoprostane in exhaled breath condensate. (2010) (35)
Bradykinin-induced airway microvascular leakage is potentiated by captopril and phosphoramidon. (1991) (35)
Inhaled glucocorticoids: new developments relevant to updating of the asthma management guidelines. (1996) (35)
Effect of inhibition of nitric oxide synthase on Pseudomonas aeruginosa infection of respiratory mucosa in vitro. (1998) (35)
Glucocorticoids reduce tachykinin NK2 receptor expression in bovine tracheal smooth muscle. (1998) (34)
New therapies for asthma. (2006) (34)
Protein kinase C isoenzymes in airway smooth muscle. (1997) (34)
[3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung. (1989) (34)
Correlation between Eicosanoids in Bronchoalveolar Lavage Fluid and in Exhaled Breath Condensate (2011) (34)
Day-night patterns in bronchial patency and dyspnea: basis for once-daily and unequally divided twice-daily theophylline dosing schedules. (1987) (34)
Muscarinic autoreceptors in airways. Their possible role in airway disease. (1989) (34)
Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue. (1991) (34)
Mechanisms and modulation of airway plasma exudation after direct inhalation of cigarette smoke. (1995) (34)
Biochemistry of asthma. (1991) (33)
Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. (1989) (33)
Effect of frusemide on cough responses to chloride-deficient solution in normal and mild asthmatic subjects. (1993) (33)
Diuretics and asthma. (1993) (33)
Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD. (2015) (33)
Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C. (1996) (33)
Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer. (2015) (33)
Cellular endotoxin desensitization in patients with severe chronic heart failure (2005) (33)
Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study. (2008) (33)
Activation of alpha-adrenergic response in tracheal smooth muscle: a postreceptor mechanism. (1983) (33)
Induction of macrophage inflammatory protein 2 gene expression by interleukin 1 beta in rat lung. (1995) (33)
Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction. (1983) (33)
Is there a role for immunotherapy in the treatment of asthma? No. (1996) (33)
Histamine H3 receptors modulate antigen-induced bronchoconstriction in guinea pigs. (1990) (32)
Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. (2002) (32)
Molecular mechanisms of antiasthma therapy. (1995) (32)
Defective sirtuin-1 increases IL-4 expression through acetylation of GATA-3 in patients with severe asthma. (2016) (32)
Histamine receptors in the lung. (1991) (32)
A role for M(2) and M(3) muscarinic receptors in the contraction of rat and human small airways. (2013) (32)
Comparison of the effects of salmeterol and formoterol in patients with severe asthma. (2002) (32)
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD (2017) (32)
Air pollution and asthma: molecular mechanisms. (1995) (31)
Anti-IgE antibody therapy for asthma. (1999) (31)
Hydroxyurea-induced hypersensitivity pneumonitis: A case report and literature review. (2000) (31)
Muscarinic receptor subtypes in the porcine lung during postnatal development. (1998) (31)
Treatment with (R)-albuterol has no advantage over racemic albuterol. (2006) (31)
Overview of neural mechanisms in asthma. (1995) (31)
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials (2017) (31)
Tumour necrosis factor alpha causes retention of activated glucocorticoid receptor within the cytoplasm of A549 cells. (1996) (31)
Role of K+ channels in the modulation of cholinergic neural responses in guinea‐pig and human airways. (1992) (31)
Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma. (1997) (31)
Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a 'two-component' model. (1999) (31)
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. (1980) (31)
Transforming growth factor-β1 inhibits β2-adrenoceptor gene transcription (2000) (30)
Review of exhaled nitric oxide in chronic obstructive pulmonary disease (2012) (30)
Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control (2007) (30)
Localisation and expression of β-adrenoceptor subtype mRNAs in human lung (1996) (30)
Bronchoconstriction and airway microvascular leakage in guinea pigs sensitized with trimellitic anhydride. (1992) (30)
Muscarinic receptor subtypes in lung. Clinical implications. (1990) (30)
Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis. (1996) (30)
A system for the production and delivery of monodisperse salbutamol aerosols to the lungs. (2003) (30)
Inhibition of fetal calf serum-stimulated proliferation of rabbit cultured tracheal smooth muscle cells by selective inhibitors of protein kinase C and protein tyrosine kinase. (1995) (29)
Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor. (1991) (29)
Pathogenesis of COPD and Asthma. (2016) (29)
Novel drugs for treating asthma (2001) (29)
Therapy of chronic obstructive pulmonary disease. (2003) (29)
Priming of circulating human eosinophils following late response to allergen challenge. (1996) (29)
Potential novel therapies for chronic obstructive pulmonary disease. (2001) (29)
Differential inhibitory effects of opioids on cigarette smoke, capsaicin and electrically‐induced goblet cell secretion in guinea‐pig trachea (1992) (29)
Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease (2019) (29)
Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold? (2015) (29)
A novel approach to partition central and peripheral airway nitric oxide. (2014) (29)
Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease (2014) (28)
Sarcoidosis: Role of non-tuberculosis mycobacteria and Mycobacterium tuberculosis. (2014) (28)
Chronic systemic administration of salmeterol to rats promotes pulmonary β2‐adrenoceptor desensitization and down‐regulation of Gsα (2001) (28)
Involvement of inflammatory mediators in the airway responses to trimellitic anhydride in sensitized guinea‐pigs (1992) (28)
The effects of almitrine on the ventilatory response to hypoxia and hypercapnia in normal subjects. (1982) (28)
Protective effect of loop diuretics, piretanide and frusemide, against sodium metabisulphite-induced bronchoconstriction in asthma. (1992) (28)
The evolving algorithm of biological selection in severe asthma (2020) (28)
High affinity [3H]formoterol binding sites in lung: characterization and autoradiographic mapping. (1994) (28)
Epigenetics and Chromatin Remodeling Play a Role in Lung Disease (2011) (28)
Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. (1999) (28)
Neutrophils Find Smoke Attractive (2010) (28)
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial (2021) (28)
exhaled nitric oxide : a marker of airway inflammation? (1996) (28)
Long‐term carbachol treatment‐induced down‐regulation of muscarinic M2‐receptors but not m2 receptor mRNA in a human lung cell line (1995) (28)
Corticosteroid modulation of immunoglobulin expression and B‐cell function in COPD (2016) (28)
Effect of platelet activating factor on formation and composition of airway fluid in the guinea‐pig trachea. (1990) (28)
Lack of effect of zaprinast on methacholine‐induced contraction and inositol 1,4,5‐trisphosphate accumulation in bovine tracheal smooth muscle (1991) (28)
Muscarinic and beta-adrenergic receptor expression in peripheral lung from normal and asthmatic patients. (1996) (27)
Non-adrenergic non-cholinergic neural control of human airways. (1986) (27)
Cholinergic control of human airways in vitro following extrinsic denervation of the human respiratory tract by heart-lung transplantation. (1990) (27)
Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs. (1993) (27)
Autonomic Control of the Respiratory System (1997) (26)
Similarities and differences in inflammatory mechanisms of asthma and COPD (2011) (26)
Salmeterol in paediatric asthma. (2000) (26)
Pulmonary α-adrenoceptors: Autoradiographic localization using [3H]prazosin (1983) (26)
Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-α generation from human peripheral blood monocytes (2007) (26)
Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children. (2005) (26)
Novel therapy for asthma (2000) (26)
Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging. (2014) (26)
Lung type II cell and macrophage annexin I release: differential effects of two glucocorticoids. (1999) (26)
Role of nitric oxide and superoxide anions in interleukin-1 beta-induced airway hyperresponsiveness to bradykinin. (1994) (26)
Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma. (1995) (26)
The effect of inhaled nifedipine on bronchial reactivity to histamine in man. (1985) (26)
Validation of the Exhaled Breath Temperature Measure: Reference Values in Healthy Subjects (2017) (25)
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study. (2020) (25)
Cholinergic mechanisms in bronchial hyperresponsiveness and asthma (1991) (25)
Effects of aerosolised substance P on lung resistance in guinea‐pigs: a comparison between inhibition of neutral endopeptidase and angiotensin‐converting enzyme (1990) (25)
Expression and activation of protein kinase C-ζ in eosinophils after allergen challenge. (1999) (25)
Inhibition of cholinergic neurotransmission in guinea pig trachea by NS1619, a putative activator of large-conductance, calcium-activated potassium channels. (1998) (25)
GM-CSF expression in pulmonary epithelial cells is regulated negatively by posttranscriptional mechanisms. (2001) (25)
Vagal control of guinea pig tracheal smooth muscle: lack of involvement of VIP or nitric oxide. (1993) (25)
Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma. (2004) (25)
Transforming growth factor-beta 1 induces transcriptional down-regulation of m2 muscarinic receptor gene expression. (1996) (25)
Pharmacological modulation of inhaled sodium metabisulphite‐induced airway microvascular leakage and bronchoconstriction in the guinea‐pig (1992) (25)
The burden of exacerbations in mild asthma: a systematic review (2020) (25)
Senotherapy: a new horizon for COPD therapy. (2020) (25)
Ezrin, a Membrane Cytoskeleton Cross‐Linker Protein, as a Marker of Epithelial Damage in Asthma (2018) (25)
Triple inhalers for obstructive airways disease: will they be useful? (2011) (25)
A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma. (2017) (24)
Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-1 and -2. (1999) (24)
Involvement of tachykinin receptors (NK1 and NK2) in sodium metabisulfite-induced airway effects. (1994) (24)
Involvement of hydroxyl radicals in neurogenic airway plasma exudation and bronchoconstriction in guinea‐pigs in vivo (1996) (24)
Bombesin-induced bronchoconstriction in the guinea pig: mode of action. (1991) (24)
Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease (2017) (24)
Autoradiographic localization of changes in pulmonary beta-adrenoceptors in an animal model of atopy. (1989) (24)
Involvement of IL-13 in tobacco smoke-induced changes in the structure and function of rat intrapulmonary airways. (2010) (24)
β2-Adrenoceptor Agonist-Induced Upregulation of Tachykinin NK2 Receptor Expression and Function in Airway Smooth Muscle (1999) (24)
Inhibition of sodium metabisulphite induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products. (1994) (24)
Effect of nedocromil sodium on airway sensory nerves. (1993) (24)
New treatments for chronic obstructive pulmonary disease. (2001) (24)
Chronic cough and Holmes-Adie syndrome (2007) (24)
Neuropeptide Y modulates non-adrenergic, non-cholinergic neural bronchoconstriction in vivo and in vitro (1989) (24)
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy (2011) (24)
Modulation of neural bronchoconstrictor responses in the guinea pig respiratory tract by vasoactive intestinal peptide (1991) (23)
Sensory Nerves, Neuropeptides, and Asthma (1991) (23)
Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells. (2005) (23)
Anti-leukotrienes: here to stay? (2003) (23)
Inflammation in COPD (2011) (23)
Endogenous opiates and the control of breathing in normal subjects and patients with chronic airflow obstruction. (1982) (23)
Bronchodilators: Basic Pharmacology (1995) (23)
Effect of 5-HT1A receptor agonist, 8-OH-DPAT, on cough responses in the conscious guinea pig. (1997) (23)
5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene. (2005) (23)
Asthma. New therapeutic approaches. (1992) (23)
Effect of bradykinin on airway neural responses in vitro. (1992) (23)
Prostacyclin binding to guinea pig pulmonary receptors. (1981) (23)
Low‐dose theophylline does not exert its anti‐inflammatory effects in mild asthma through upregulation of interleukin‐10 in alveolar macrophages (2001) (23)
Peptide mediator effects on bronchial blood velocity and lung resistance in conscious sheep. (1992) (22)
Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage. (1991) (22)
Cholecystokinin‐octapeptide constricts guinea‐pig and human airways (1989) (22)
Capsaicin pretreatment does not inhibit allergen‐induced airway microvascular leakage in guinea pig (1991) (22)
Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients (2000) (22)
Contraction of human airway smooth muscle by endothelin-1 and IRL 1620: effect of bosentan. (1997) (22)
Overcoming steroid insensitivity in smoking asthmatics. (2008) (22)
Endogenous plasma adrenaline in asthma. (1983) (22)
Effect of formoterol, a long-lasting beta 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction. (1990) (22)
Difficult asthma. (1989) (22)
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD (2018) (22)
Inflammatory Response to Sputum Induction Measured by Exhaled Markers (2005) (22)
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD (2015) (22)
Downregulation of MicroRNA-126 Augments DNA Damage Response in Cigarette Smokers and COPD Patients. (2017) (22)
Effect of bradykinin on airway function. (1992) (22)
Oxidative Stress in Chronic Obstructive Pulmonary Disease (2014) (22)
Pulmonary Diseases and Ageing. (2019) (22)
Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo. (2000) (21)
Asthma and COPD : basic mechanisms and clinical mamagement (2002) (21)
Chronic heart failure in the guinea pig increases cardiac alpha 1- and beta-adrenoceptors. (1980) (21)
ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK. (2004) (21)
Inhibition of excitatory non‐adrenergic non‐cholinergic bronchoconstriction in guinea‐pig airways in vitro by activation of an atypical 5‐HT receptor (1994) (21)
Neuroimmune Interactions in the Lung (1992) (21)
Activation of guinea pig pulmonary adenylate cyclase by prostacyclin. (1980) (21)
Duration of protection by oxitropium bromide against cholinergic challenge. (1987) (21)
Neuropeptides and airway smooth muscle. (1988) (21)
Real-time measurement of particulate matter deposition in the lung (2006) (21)
STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects (2012) (21)
Glucocorticoid resistance in infl ammatory diseases (2009) (21)
Symptoms and perception of airway obstruction in asthma: clinical implications for use of reliever medications. (2019) (21)
Novel therapy for COPD (2000) (21)
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial (2015) (21)
Ceramide lances the lungs (2004) (21)
Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative (2018) (21)
K+ channel activator inhibition of neurogenic goblet cell secretion in guinea pig trachea. (1992) (21)
Anti‐spasmogenic activity of isoenzyme‐selective phosphodiesterase inhibitors in guinea‐pig trachealis (1999) (21)
The allergen challenge (2002) (21)
Differential IκB Kinase Activation and IκBα Degradation by Interleukin-1β and Tumor Necrosis Factor-α in Human U937 Monocytic Cells (1999) (21)
Characterization of the effects of cannabinoids on guinea‐pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves (2000) (21)
Activation of Transcription Factor Nrf2 Signalling by the Sphingosine Kinase Inhibitor SKI-II Is Mediated by the Formation of Keap1 Dimers (2014) (21)
Effect of maturation on histamine-induced airflow obstruction and airway microvascular leakage in guinea pig airways. (1992) (21)
The Future of COPD (2011) (20)
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma (2014) (20)
Isoniazid for the Tuberculin Reactor: Take it or Leave it (1988) (20)
Effect of 8-iso-prostaglandin F2α on acetylcholine release from parasympathetic nerves in guinea pig airways (2001) (20)
Update in chronic obstructive pulmonary disease 2011. (2012) (20)
Agonist-induced up-regulation of platelet-activating factor receptor messenger RNA in human monocytes. (1994) (20)
Looking for Airways Periostin in Severe Asthma: Could It Be Useful for Clustering Type 2 Endotype? (2018) (20)
Our changing understanding of asthma. (1989) (20)
Pathogenesis of Asthma: A Review (1983) (20)
Hydrogen Peroxide Reverses IL-5 Afforded Eosinophil Survival and Promotes Constitutive Human Eosinophil Apoptosis (2002) (20)
Neuropeptides and airway smooth muscle function. (1987) (20)
Future directions for the ERS: Presidential plans (2013) (20)
Transforming growth factor-beta1 inhibits beta2-adrenoceptor gene transcription. (2000) (20)
Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal. (2012) (20)
Effect of acute and chronic inhaled furosemide on bronchial hyperresponsiveness in mild asthma. (1995) (20)
Fetal pulmonary beta-adrenergic receptors: characterization in the human and in vitro modulation by glucocorticoids in the rabbit. (1985) (20)
Inhibition of ozone-induced lung neutrophilia and nuclear factor-kappaB binding activity by vitamin A in rat. (1999) (20)
The effect of body weight on distal airway function and airway inflammation. (2016) (20)
What is the role of nerves in chronic asthma and symptoms? (1996) (19)
Potentiation of nonadrenergic neural relaxation in guinea pig airways by a cyclic cAMP phosphodiesterase inhibitor. (1990) (19)
Feasibility and interpretation of FE(NO) measurements in asthma patients in general practice. (2008) (19)
Bacterial load and defective monocyte-derived macrophage bacterial phagocytosis in biomass smoke-related COPD (2019) (19)
Evidence for post‐transcriptional regulation of interleukin‐5 by dexamethasone (2003) (19)
COPD 2020: new directions needed. (2020) (19)
β2-Agonists Potentiate Corticosteroid-Induced Neutrophil Survival (2008) (19)
Neural control of airway function: new perspectives. (1990) (19)
Theophylline and phosphodiesterase inhibitors. (1995) (19)
Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism (2016) (19)
Regulation of m2 muscarinic receptor gene expression by platelet-derived growth factor: involvement of extracellular signal-regulated protein kinases in the down-regulation process. (1997) (19)
A Polymorphism Affecting MYB Binding within the Promoter of the PDCD4 Gene is Associated with Severe Asthma in Children (2013) (19)
Pharmacological comparison of LTB4‐induced NADPH oxidase activation in adherent and non‐adherent guinea‐pig eosinophils (2001) (19)
Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49]. (2017) (19)
Reduced HDAC2 in skeletal muscle of COPD patients (2017) (19)
Plasma histamine concentration during propranolol induced bronchoconstriction. (1985) (19)
Epithelial modulation of non-adrenergic, non-cholinergic and vasoactive intestinal peptide-induced responses: role of neutral endopeptidase. (1989) (19)
Prostaglandins mediate bradykinin-induced reduction of exhaled nitric oxide in asthma. (1999) (19)
Role of neutral endopeptidase in bronchial hyperresponsiveness to bradykinin induced by IL-1 beta. (1995) (18)
Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma. (1998) (18)
Gi-dependent suppression of β1-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs (2000) (18)
Decreased percentage of CD4+Foxp3+TGF-β+ and increased percentage of CD4+IL-17+ cells in bronchoalveolar lavage of asthmatics (2014) (18)
Modulation of neurotransmission in guinea-pig airways by galanin and the effect of a new antagonist galantide (1994) (18)
Oscillating Positive Expiratory Pressure on Respiratory Resistance in Chronic Obstructive Pulmonary Disease With a Small Amount of Secretion (2015) (18)
Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma. (2006) (18)
Molecular basis for corticosteroid action in asthma. (2000) (18)
Bombesin stimulates human nasal mucous and serous cell secretion in vivo. (1992) (18)
Neurogenic inflammation in the airways: characterisation of electrical parameters for vagus nerve stimulation in the guinea pig (1990) (18)
Chronic Obstructive Pulmonary Disease: Cellular and Molecular Mechanisms (2005) (18)
The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells. (2007) (18)
Vagal stimulation induces increased pulmonary vascular permeability in guinea pig. (1994) (18)
Brittle asthma. (1998) (18)
Downregulation of MicroRNA‐126 Augments DNA Damage Response in Cigarette Smokers and Patients with Chronic Obstructive Pulmonary Disease (2018) (18)
Albuterol does not antagonize the inhibitory effect of dexamethasone on monocyte cytokine release. (1998) (18)
Assessment of reproducibility of exhaled hydrogen peroxide concentration and the effect of breathing pattern in healthy subjects. (2011) (18)
A Comparison of Low-Dose Inhaled Budesonide Plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma (1998) (17)
Muscarinic receptor subtypes: implications for therapy. (1993) (17)
Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease. (2016) (17)
H3 receptors in airways. (1989) (17)
Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation. (1994) (17)
A single inhaler for asthma? (2005) (17)
The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial (2020) (17)
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD (2014) (17)
Effects of ipratropium bromide on bradykinin nasal provocation in chronic allergic rhinitis (1994) (17)
Nitric oxide and asthma. (1995) (17)
Effect of an inhaled histamine H3-receptor agonist on airway responses to sodium metabisulphite in asthma. (1993) (17)
Introduction: how can we improve asthma management? (2005) (17)
The effect of anion transport inhibitors and extracellular Cl- concentration on eosinophil respiratory burst activity. (1992) (17)
Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis (2014) (17)
Interleukin-10 modulates pulmonary neutrophilic inflammation induced by cigarette smoke exposure (2015) (17)
Localisation and expression of beta-adrenoceptor subtype mRNAs in human lung. (1996) (17)
Bronchodilation using combined urodilatin - albuterol administration in asthma: a randomized, double-blind, placebo-controlled trial. (1999) (17)
Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. (1994) (17)
Asthma mechanisms (2016) (17)
Allergen-induced airway hyperresponsiveness in Brown-Norway rat: role of parasympathetic mechanisms. (1993) (17)
Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics (1993) (17)
Bronchoconstriction induced by inhaled sodium metabisulfite in the guinea pig. Effect of capsaicin pretreatment and of neutral endopeptidase inhibition. (1990) (17)
Osteoprotegerin in sputum is a potential biomarker in COPD. (2011) (17)
A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. (1992) (17)
Effect of thiazide diuretics against neurally mediated contraction of guinea pig airways. Contribution of carbonic anhydrase. (1993) (17)
Characterization of the generation of radiolabeled monodisperse albuterol particles using the spinning-top aerosol generator. (2004) (17)
Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma. (1998) (17)
Reduced Clearance of Fungal Spores by Chronic Obstructive Pulmonary Disease GM-CSF- and M-CSF-derived Macrophages. (2018) (17)
The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure (2003) (17)
Breakdown of phosphoinositides in airway smooth muscle: lack of influence of anti-asthmatic drugs. (1987) (16)
Ultrastructural characterization of platelet-activating factor-stimulated human eosinophils from patients with asthma. (1993) (16)
Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis (2017) (16)
Radioligand binding studies of adrenergic receptors and their clinical relevance. (1981) (16)
Neutrophil influx into guinea-pig airway lumen during cholinergic and non-cholinergic bronchoconstriction. (1992) (16)
Effect of a topical corticosteroid on airway hyperresponsiveness and eosinophilic inflammation induced by trimellitic anhydride exposure in sensitized guinea pigs. (1993) (16)
Pharmacology of the respiratory tract : experimental and clinical research (1993) (16)
Normal bronchial blood flow in COPD is unaffected by inhaled corticosteroids and correlates with exhaled nitric oxide. (2007) (16)
Emerging targets for COPD therapy. (2005) (16)
Oxidative stress induces NFkB DNA binding and inducible NOS mRNA in the human epithelial cell line A549 (1994) (16)
Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial (2011) (16)
The Pressing Need to Redefine "COPD". (2019) (15)
Superinduction of COX-2 mRNA by cycloheximide and interleukin-lp involves increased transcription and correlates with increased (1997) (15)
Identification of neutral endopeptidase mRNA in human nasal mucosa. (1993) (15)
Vasoactive intestinal peptide and asthma. (1989) (15)
A short tour around the muscarinic receptor. (1988) (15)
Calcium, calcium channel blockade and airways function. (2009) (15)
Recent advances in asthma. (1992) (15)
Neurogenic goblet cell secretion and bronchoconstriction in guinea pigs sensitised to trimellitic anhydride. (1995) (15)
PAF antagonists. Their potential therapeutic role in asthma. (1988) (15)
Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man. (1991) (15)
Optimizing sputum methodology (2002) (15)
Chemokine receptor CXCR2 antagonism to prevent airways inflammation (2011) (15)
New approaches to COPD (2005) (14)
3 – Non-Saponifiable Lipids in Cereals (1983) (14)
Role of autophagy in regulating interleukin-10 and the responses to corticosteroids and statins in asthma. (2021) (14)
Ventilatory effects of substance P, vasoactive intestinal peptide, and nitroprusside in humans. (1990) (14)
Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function (2018) (14)
Bronchodilating effects of the novel potassium channel opener HOE 234 in human airways in vitro. (1993) (14)
Inhaled frusemide and asthma (1990) (14)
Bradykinin-induced Bronchoconstriction in Humans (2015) (14)
Muscarinic m_3 receptor mRNA in situ hybridization in human nasal mucosa (1992) (14)
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis (2022) (14)
Asthma and COPD (2009) (13)
Role for platelet-activating factor in asthma (1991) (13)
Differential effects of phosphoramidon on neurokinin A‐ and substance P‐induced airflow obstruction and airway microvascular leakage in guinea‐pig (1991) (13)
Brittle asthma (1998) (13)
Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha). (2001) (13)
IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice (2021) (13)
The effect of inhaled K+ channel openers on bronchoconstriction and airway microvascular leakage in anaesthetised guinea pigs. (1996) (13)
Sensory nerve depletion potentiates inhibitory non-adrenergic, non-cholinergic nerves in guinea-pig airways. (1990) (13)
Modulation of Neurotransmitter Release from Airways Nerves (1994) (13)
Liquid chromatography / mass spectrometry analysis of exhaled leukotriene B 4 in asthmatic children (2005) (13)
Adrenergic and cholinergic receptors in submucosal glands of the ferret trachea: autoradiographic localization. (1983) (13)
Drugs for airway disease (2003) (13)
Characterization and autoradiographic mapping of [3H]CP96,345, a nonpeptide selective NK1 receptor antagonist in guinea pig lung (1995) (13)
Can We Define Asthma-COPD Overlap (ACO) by Biomarkers? (2019) (13)
Circulating autoantibodies to recombinant lipocortin-1 in asthma. (1991) (13)
New drugs and targets for asthma and COPD (2010) (13)
Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients. (2017) (13)
Drug-induced Asthma (1998) (12)
Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis (2017) (12)
Airway hyperresponsiveness to acetylcholine and to tachykinins after respiratory virus infection in the guinea pig. (1993) (12)
Methylxanthines and phosphodiesterase inhibitors in the treatment of airways disease (1996) (12)
Con: Genome-wide association studies have not been useful in understanding asthma. (2011) (12)
Bradykinin receptor subtypes in rat lung: effect of interleukin-1 beta. (1995) (12)
Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemia. (2004) (12)
Effect of cigarette smoking on haem-oxygenase expression in alveolar macrophages. (2004) (12)
Telomere Shortening in Alveolar Macrophages of Smokers and COPD Patients~!2010-02-18~!2010-03-05~!2010-04-15~! (2010) (12)
The management of newly identified asthma in primary care in England. (2002) (12)
Effects of Anti-IL-13 (Novartis QAX576) on Inflammatory Responses Following Nasal Allergen Challenge (NAC). (2009) (12)
Oxidative stress and cardiovascular complications in sleep apnea. (2005) (12)
Modulation of nonadrenergic noncholinergic neural bronchoconstriction by bradykinin in anesthetized guinea pigs in vivo. (1994) (12)
GOLD 2017: A New Report. (2017) (12)
Chronic Obstructive Pulmonary Disease Endotypes in Low- and Middle-Income Country Settings: Precision Medicine for All (2020) (12)
TUMOR NECROSIS FACTOR ALTERS HUMAN BRONCHIAL REACTIVITY AND INDUCES INFLAMMATORY CELL INFLUX (1993) (12)
Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD (2021) (12)
Ibuprofen augments bradykinin-induced glycoconjugate secretion by human nasal mucosa in vivo. (1992) (12)
Future treatments (2006) (12)
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee (2019) (12)
Asthma: what is there left to find out? (1993) (12)
Prevalence of COPD in a rural population in India (2011) (12)
Effects of treatment on airway microvascular leakage. (1990) (12)
Effect of a bradykinin receptor antagonist, HOE 140, against bradykinin- and vagal stimulation-induced airway responses in the guinea-pig. (1994) (11)
Prazosin, an alpha 1-adrenoceptor antagonist, partially inhibits exercise-induced asthma. (1981) (11)
Coordinated regulation of IL-4 and IL-13 expression in human T cells: 3C analysis for DNA looping. (2011) (11)
β-Adrenergic agonists and bronchial hyperreactivity: Role of β2-adrenergic and tachykinin neurokinin-2 receptors (2000) (11)
Exhaled Breath Analysis (2001) (11)
Respiratory diseases in the world: one voice “united for lung health” (2014) (11)
Chronic lung diseases: prospects for regeneration and repair (2021) (11)
New concepts in the pathogenesis of bronchial hyperresponsiveness. (1987) (11)
Differential down-regulation of pulmonary beta 1- and beta 2-adrenoceptor messenger RNA with prolonged in vivo infusion of isoprenaline. (1993) (11)
Mu-opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways. (1987) (11)
Regulatory peptides in the respiratory system (1987) (11)
Adrenergic receptors of normal and asthmatic airways. (1984) (11)
Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. (1988) (11)
Role of Endothelium in the Control of Pulmonary Vascular Tone (1994) (11)
Beta 2-adrenergic receptors on eosinophils. Binding and functional studies. (1990) (11)
Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion. (1990) (11)
Leukotriene B4 release by human lung macrophages via receptor- not voltage-operated Ca2+ channels (2009) (11)
Muscarinic receptors in lung. (1987) (11)
Effect of theophylline plus beclometasone on lung function in smokers with asthma-a pilot study (2009) (11)
EXHALED NITRIC OXIDE IN MONITORING ASTHMA (1997) (11)
Inflammatory Markers: Exhaled Nitric Oxide and Carbon Monoxide During the Ovarian Cycle (2011) (11)
Transcription Factors in Asthma (1998) (11)
Autoradiographic localization of leukotriene C4 and D4 binding sites in guinea-pig lung. (1988) (11)
Effect of acetazolamide and amiloride against sodium metabisulphite-induced bronchoconstriction in mild asthma. (1994) (11)
Efficacy and safety of as-needed budesonide-formoterol in adolescents with mild asthma. (2021) (11)
Endo-phenotyping of COPD patients (2020) (11)
The acute effect of swimming on airway inflammation in adolescent elite swimmers. (2009) (11)
Molecular biology and respiratory disease. 5. Molecular biology of receptors: implications for lung disease. (1990) (11)
Modulation of bradykinin responses in airway smooth muscle by epithelial enzymes (1990) (11)
Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity (2017) (11)
Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man. (1990) (10)
Inhaled sodium cromoglycate in children with asthma (10)
Autoradiographic localisation of beta-adrenoceptors in human lung. (1984) (10)
Molecular biology of receptors. (1992) (10)
Calcium channel blockade and asthma--the current position. (1985) (10)
Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients. (2011) (10)
Adenosine 5’-triphosphate’s role in bradycardia and syncope associated with pulmonary embolism (2018) (10)
Molecular biology of lung disease (1994) (10)
COUNTERPOINT: Will New Anti-eosinophilic Drugs Be Useful in Asthma Management? No. (2017) (10)
Strategies for novel COPD therapies. (1999) (10)
PAF, eosinophils and asthma. (1992) (10)
Effect of short- and long-acting beta 2-adrenoceptor agonists on pulmonary beta 2-adrenoceptor expression in human lung. (1996) (10)
Future drug therapy for asthma (1991) (10)
Budesonide facilitates weaning from mechanical ventilation in difficult‐to‐wean very severe COPD patients: Association with inflammatory mediators and cells (2018) (10)
Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway (2016) (10)
A fluorescent analogue of propranolol does not label beta adrenoceptor sites (1980) (10)
Dual Transmembrane Signalling Mechanisms in Eosinophils: Evidence for Two Functionally Distinct Receptors for Platelet-Activating Factor. (1992) (10)
Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888. (1993) (9)
Characterization of phosphodiesterase 4 in guinea‐pig macrophages: multiple activities, association states and sensitivity to selective inhibitors (1998) (9)
Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model (2020) (9)
Beta 2-agonists and corticosteroids: new developments and controversies. Report of a meeting in November 1990. (1992) (9)
Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in Brown-Norway rats (1995) (9)
Clinical outcome of adding long-acting beta-agonists to inhaled corticosteroids. (2001) (9)
Virus-Induced Asthma Exacerbations: SIRT1 Targeted Approach (2020) (9)
Interactions of glucocorticoids and β 2-agonists (2002) (9)
Sputum induction as a method of analyzing pulmonary cells: reproducibility and acceptability. (1999) (9)
Expression and activation of protein kinase C-zeta in eosinophils after allergen challenge. (1999) (9)
Effect of frusemide on the induction and potentiation of cough induced by prostaglandin F2 alpha. (1992) (9)
Hepatocyte growth factor deficiency in COPD: a mechanism of emphysema and small airway fibrosis? (2014) (9)
Chapter 35 – Pathophysiology of Asthma (2002) (9)
Regulation of H1‐receptor coupling and H1‐receptor mRNA by histamine in bovine tracheal smooth muscle (1998) (9)
What the journal would like to publish on chronic obstructive pulmonary disease. (2010) (9)
Inhaled Aerosol Distribution in Human Airways: A Scintigraphy-Guided Study in a 3D Printed Model. (2016) (9)
Pharmacology of eosinophils (1993) (9)
Epithelium-Dependent Responsiveness of Airway Smooth Muscle: The role of Epithelium-Derived Relaxant Factors (1997) (9)
Club cells, their secretory protein, and COPD. (2015) (9)
Treatment of asthma. (1987) (9)
Theophylline iin tthe m management oof aasthma: time ffor rreappraisal? (1994) (9)
The effect of platelet activating factor on pulmonary beta-adrenoceptors. (1987) (9)
Intramuscular triamcinolone in severe asthma. (1991) (9)
Autonomic pharmacology of the airways (1993) (9)
New treatments for asthma (2000) (9)
Exhaled Breath Condensate (2004) (9)
RELEASE OF FIBROBLAST PROLIFERATIVE ACTIVITY FROM CULTURED HUMAN AIRWAY EPITHELIAL-CELLS - A ROLE FOR INSULIN-LIKE GROWTH FACTOR-I (IGF-1) (1993) (9)
The novel inhaled glucocorticoid receptor agonist GW870086X protects against adenosine-induced bronchoconstriction in asthma. (2015) (9)
Adrenergic and non-adrenergic, non-cholinergic control of airways. (1986) (9)
Bicaudal D1 impairs autophagosome maturation in chronic obstructive pulmonary disease (2019) (9)
Neural mechanisms in asthma: New developments (1997) (9)
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure. (2003) (8)
Cigarette smoke-induced impairment of autophagy in macrophages increases galectin-8 and inflammation (2021) (8)
Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity (2016) (8)
Immunomodulation as asthma therapy: where do we stand? (1996) (8)
Principles of asthmaDrugs for airway disease (2008) (8)
Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2 (2021) (8)
Platelet Activating Factor and Asthma (1991) (8)
BET proteins are a key component of immunoglobulin gene expression (2017) (8)
Beta‐adrenoceptors and asthma (1993) (8)
Pathophysiology of COPD (2009) (8)
Defective antioxidant gene regulation in COPD: a case for broccoli. (2008) (8)
Editorial: the Journal of COPD--new directions in disease understanding and management. (2004) (8)
Cells and mediators of chronic obstructive pulmonary disease (2006) (8)
Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy. (2020) (8)
Mediators and asthma. (1985) (8)
Molecular Mechanisms of Anti-Asthma Therapy (1995) (8)
19 – Wheat Germ Oil (1983) (8)
Exhaled breath temperature in asthma (2003) (8)
Neural and Humoral Control (2002) (8)
Effect of nedocromil sodium on down-regulation of pulmonary beta-adrenoceptors. (1989) (8)
Mechanisms of Disease Airway receptors (2008) (8)
Muscarinic M2 receptor synthesis: study of receptor turnover with propylbenzilylcholine mustard. (1995) (8)
Increased Eosinophil Responsiveness to Platelet-Activating Factor in Asthma (1988) (8)
Effect of theophylline on airway responses to inhaled platelet-activating factor in man. (1989) (7)
Inhibitory effects of sulfonated shale oil fractions on the oxidative burst and Ca++ mobilization in stimulated macrophages. (1994) (7)
Neurogenic inflammation in airways. (1991) (7)
Bronchodilator and Catecholamine Responses to Induced Hypoglycaemia in Acute Asthma (1985) (7)
Rebuttal from dr. barnes (2006) (7)
Reproducibility of heart rate changes following adenosine infusion in man (2004) (7)
Platelet activating factor stimulates a receptor-coupled membrane GTPase in guinea pig eosinophils. (1993) (7)
Diagnostic Performance Of An Electronic Nose, Fractional Exhaled Nitric Oxide And Lung Function Testing In Asthma (2010) (7)
Exhaled nitric oxide comes of age (2012) (7)
Vasoactive intestinal peptide and pulmonary function (1987) (7)
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies (2021) (7)
Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of COPD (2015) (7)
Inhibition of neurogenic plasma exudation and bronchoconstriction by a K+ channel activator, BRL 38227, in guinea pig airways in vivo. (1993) (7)
Clinical Tuberculosis 4th Edition (2008) (7)
Synergy between Tumor Necrosis Factor α and Interleukin 1β in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression (1996) (7)
beta(2)-adrenoceptor agonist-induced upregulation of tachykinin NK(2) receptor expression and function in airway smooth muscle. (1999) (7)
Neuropeptides as modulators of airway function. (1990) (7)
Asthma therapy: basic mechanisms. (1986) (7)
Theophylline in Chronic Obstructive Pulmonary Disease (2012) (7)
Advances in chronic obstructive pulmonary disease. (2002) (7)
Anticholinergic Blockade of Beta-Blocker-Induced Bronchoconstriction (1990) (7)
Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation (2019) (7)
GINA Workshop Report (Updated 2004) Global Strategy for Asthma Management and Prevention (2005) (7)
In vivo identification and distribution of alpha- and beta-adrenoceptors in rat heart and lung. (1982) (7)
Allergic inflammatory mediators and bronchial hyperresponsiveness : an introductory overview (1990) (7)
Increased interleukin-10 and macrophage inflammatory protein-1 alpha release from blood monocytes ex vivo during late-phase response to allergen in asthma. (2000) (7)
Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects (2004) (7)
New Drugs for Asthma (2012) (7)
Lung type II cell and macrophage annexin I release: differential effects of two glucocorticoids. (1999) (7)
Postnatal changes in β‐adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn (2002) (6)
γ-Tocopherol in barley germ (1981) (6)
Biochemistry of airway smooth muscle. (1986) (6)
Low‐Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease (2019) (6)
ASTHMA THERAPY — PRESENT ANXIETIES AND FUTURE RESEARCH (1992) (6)
Extracellular signal‐regulated kinase 1/2 control Ca2+‐independent force development in histamine‐stimulated bovine tracheal smooth muscle (2000) (6)
Mediators of asthma: a new series. (2001) (6)
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients (2009) (6)
NANC Nerves and Neuropeptides (1998) (6)
The use of an image analyser to determine the particle size distribution of salbutamol for use in metered dose inhalation aerosols (1974) (6)
Plasma exudation into airways induced by inhaled platelet-activating factor: effect of peptidase inhibition. (1991) (6)
SARS-CoV-2 infects lung epithelial cells and induces senescence and an inflammatory response in patients with severe COVID-19 (2021) (6)
NF-kappa B involvement in IL-1 beta-induction of GM-CSF and COX-2: inhibition by glucocorticoids does not require I-kappa B. (1997) (6)
The Need for New Therapy (2001) (6)
Glucocorticoids and asthma. (2002) (6)
Autonomic control of airway function in asthma. (1987) (6)
Transcription factors and inflammatory disease. (1996) (6)
IL-5 in asthma (2002) (6)
Future perspectives on exhaled biomarkers (2010) (6)
Recent Advances in the Pathophysiology of COPD (2004) (6)
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study (2016) (6)
Cytokine Regulation of Chronic Inflammation in Asthma (1995) (6)
PAF ANTAGONISTS IN ASTHMA (1989) (6)
Mechanisms of Interleukin 1 b-Induced Human Airway Smooth Muscle Hyporesponsiveness to Histamine Involvement of p 38 MAPK and NFk B (2001) (6)
"Epithelium acts as a modulator and a diffusion barrier in the responses of canine airway smooth muscle". (1994) (6)
Effect of histamine on human bronchial arteries in vitro (1990) (6)
Dependent Protein Kinase A Human T Lymphocytes Is Not Mediated by ( cAMP )-Dependent Inhibition of IL-5 from-Cyclic Monophosphate ′ , 5 ′ Adenosine 3 (2001) (6)
Effect of olodaterol on the relaxation of small airways (2011) (6)
COPD: new developments and therapeutic opportunities. (1999) (6)
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD (2020) (6)
Aerosol delivery devices. (2006) (6)
Glucocorticosteroids in Asthma (1991) (6)
Noninvasive assessment of airway inflammation in asthma (2003) (6)
Endotoxin and steroid effects of nitric oxide synthase mRNA expression in rat lung and other tissues. (1994) (5)
Preoperative cimetidine--effects on gastric fluid. (1980) (5)
Effect of nedocromil sodium on microvascular leakage. (1993) (5)
ect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects (1998) (5)
Platelet-activating factor: a potent mediator of inflammation (1989) (5)
Inflammatory activities (1991) (5)
The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics (2014) (5)
Questions about inhaled beta 2-adrenoceptor agonists in asthma. (1992) (5)
Localization of m3 Muscarinic Receptor mRNA in Human Nasal Mucosa (1992) (5)
Reduced Denitration Activity in Peripheral Lung of Chronic Obstructive Pulmonary Disease (2012) (5)
CIRCULATING CATECHOLAMINES IN ASTHMA (1981) (5)
New drugs for asthma (1993) (5)
Preventative therapy in adults with asthma. (1991) (5)
The fate of respiratory physiology. (1994) (5)
Retraction: Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. (2014) (5)
Chemokines in COPD (2008) (5)
Airway smooth muscle and disease workshop: phosphoinositide turnover. (1987) (5)
Beclometasone Dipropionate/Formoterol in an HFA-Propelled Pressurised Metered-Dose Inhaler (2006) (5)
Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig. (1993) (5)
The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway (2014) (5)
Circadian rhythms and airway function. (1987) (5)
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians (2020) (5)
Pulmonary alpha-adrenoceptors: autoradiographic localization using [3H]prazosin. (1983) (5)
Biochemical and pharmacological interactions between the papaverine derivative, AH 21–132, and methacholine in bovine tracheal smooth muscle (1990) (5)
Demonstration of alpha 1-adrenoceptors in guinea pig lung using 3H-prazosin. (1979) (5)
Anaesthetic Complications Requiring Intensive Care: A five year review (1980) (5)
Single dose of slow-release aminonphylline at night prevents noc-turnal asthma. (1982) (5)
Chapter 50 – Theophylline (2009) (5)
Neural mechanism in asthma (1991) (5)
Localization of beta pre-protachykinin mRNA in nodose ganglion (1991) (5)
[Pathogenetic significance of eosinophilic granulocytes. I. Morphology, biochemistry and effector mechanisms]. (2008) (5)
Effect ofβ(in2)-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig (1993) (5)
INHIBITION OF MTOR RESTORES CORTICOSTEROID SENSITIVITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2015) (5)
Montelukast for persistent asthma (2001) (5)
G(i)-dependent suppression of beta(1)-adrenoceptor effects in ventricular myocytes from NE-treated guinea pigs. (2000) (5)
Why does asthma become persistent? (1996) (5)
The mode of action of corticosteroids in asthma (1998) (5)
Beta-adrenergic agonists and bronchial hyperreactivity: role of beta2-adrenergic and tachykinin neurokinin-2 receptors. (2000) (5)
Chronic obstructive pulmonary disease: important advances. (2013) (5)
CYCLOOXYGENASE-2 EXPRESSION IN AIRWAY CELLS (1998) (5)
Antigen-induced bronchial hyperresponsiveness in the rabbit is not dependent on M(2)-receptor dysfunction. (1999) (5)
Bronchial reactivity is not increased after inhalation of leukotriene B 4 and prostaglandin D 2 (1988) (5)
Tumour Necrosis Factor-a Regulates Human Eosinophil Apoptosis via Ligation of TNF-Receptor 1 and Balance between NF-kB and AP-1 (2014) (5)
Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings. (1989) (5)
Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium. (1992) (5)
Neuropeptides in human airways. (1988) (5)
Beta-agonists and death from asthma. (1992) (5)
The drug therapy of asthma: directions for the 21st century. (1988) (5)
Asthma therapy with aerosols: clinical relevance for the next decade. (1996) (5)
Isoprostanes and asthma (2006) (5)
Differential I k B Kinase Activation and I k B a Degradation by Interleukin-1 b and Tumor Necrosis Factor-a in Human U 937 Monocytic Cells (1999) (5)
Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis (2015) (5)
Nuclear factor‐κB does not mediate the inhibitory effects of dexamethasone on granulocyte–macrophage colony‐stimulating factor expression (2004) (5)
David Jack (1924–2011) who revolutionised the treatment of asthma (2012) (4)
Transcription factor interactions in human lung. (1993) (4)
Cromoglycate: Breathing life into an old asthma drug (2015) (4)
Direct Inhibitory Effect of the Phosphodiesterase-4 Inhibitor, Roflumilast, on Neutrophil Migration in COPD (2018) (4)
IL-22 enhances Calgranulin A expression by human macrophages to inhibit virulent Mycobacterium tuberculosis growth (158.21) (2011) (4)
Metabolism of 3H-arachidonic acid in male dog lung in vitro using a perfusion system designed to mimic physiological conditions. (1980) (4)
Comparison of the Cardiovascular and Respiratory Effects of Substance P and Neurokinin A in Man (1987) (4)
Molecular mechanisms of atopy. (2001) (4)
Endotoxin-induced plasma exudation in guinea-pig airways in vivo and the effect of neutrophil depletion. (1990) (4)
Inhibitory Muscarinic Receptors on Airway Cholinergic Nerves in Man: Evidence for a Defect in Asthma (1988) (4)
Role of cyclooxygenase and 5-lipoxygenase metabolites, platelet-activating factor and 5-hydroxytryptamine in allergen-induced airway responses in the brown Norway rat. (1994) (4)
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). (2016) (4)
21 – Nitric Oxide (1998) (4)
Human lung adrenoceptors identified by radioligand binding [proceedings]. (1980) (4)
Adverse reactions and the science of pharmacosurveillance (1998) (4)
Oxygen and Theophylline Reduce the Cardiorespiratory Effects of Adenosine Infusion in Han (1987) (4)
Prediction of Achievement in Grades I Through 4 From Otis Quick-Scoring Mental Ability Tests: Alpha Short Form (1955) (4)
Small airway fibroblasts from COPD patients are senescent and pro-fibrotic (2018) (4)
[Future therapies for chronic obstructive pulmonary disease]. (2006) (4)
Rapid estimation of plasma theophylline concentrations. (1985) (4)
Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease (2019) (4)
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment (2013) (4)
Managing asthma in hospital: cause for concern. (1991) (4)
Drug particle size and lung deposition in COPD (2016) (4)
The trials and tribulations of anti–IL-5 … (2002) (4)
Zafirlukast (Accolate(TM)) (1998) (4)
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease (2009) (4)
Identification of Novel Therapeutic Targets in COPD (2011) (4)
Mechanisms of Impaired b-Adrenoceptor-induced Airway Relaxation by Interleukin-1 b In Vivo in the Rat (2013) (4)
Characterization of Purified Dog Mastocytoma Cells (2015) (4)
Cytokine-directed therapies in asthma (2003) (4)
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. (2019) (4)
262 Bombesin stimulates mucous and serous cell secretion in human nasal provocation tests (1991) (4)
High concentrations of beta-adrenergic agonists inhibit DNA binding of glucocorticoids in human lung in vitro. (1995) (4)
Exhaled Nitric Oxide in Pulmonary Diseases (2010) (4)
ICS and COPD: Time to clear the air (2009) (4)
Novel mechanisms and new therapies for chronic obstructive pulmonary disease (2009) (3)
Neuropeptides and airway pathophysiology (1992) (3)
E V ect of inhaled L -arginine on exhaled nitric oxide in normal and asthmatic subjects (1998) (3)
Case Report: Ketogenic Diet Is Associated With Improvements in Chronic Obstructive Pulmonary Disease (2021) (3)
Palliative Care in COPD (2011) (3)
Histamine, Substance P and Neurogenic Flare in Human Skin (1985) (3)
Chronic obstructive pulmonary disease. (2014) (3)
The quantitative analysis of 6-keto PGF1 alpha in biological fluids by stable isotope dilution utilizing gas chromatography-mass spectrometry (GC-MS) [proceedings]. (1980) (3)
Current Therapy for Asthma (2001) (3)
New drugs for asthma. (2004) (3)
Autonomic Factors in Hyperreactivity of Airway Smooth Muscle (2011) (3)
Autonomic Control of the Lower Airways (2012) (3)
NEW TARGETS FOR FUTURE ASTHMA THERAPY (2000) (3)
The key role of microRNA-34a in the reduction of sirtuin-1 in COPD (2016) (3)
Why More Research into Molecular and Cellular Mechanisms of COPD Is Needed (2005) (3)
The role of neurotransmitters in bronchial asthma (2007) (3)
Localization and function of airway autonomic receptors. (1984) (3)
COPD: inflammatory mechanisms and systemic consequences (2013) (3)
Decision making in asthma therapy--what is important in clinical practice? (2004) (3)
Characterization of purified dog mastocytoma cells. Autonomic membrane receptors and pharmacologic modulation of histamine release. (1985) (3)
Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence (2013) (3)
Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma. (1995) (3)
Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in the human epithelial cell line A549. (1994) (3)
Are mast cells still important in asthma (2002) (3)
Studies on Respiratory Disorders (2014) (3)
Postnatal changes in beta-adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn. (2002) (3)
A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects (2016) (3)
Pathology and Immunology (2008) (3)
Opioid modulation ofnon-cholinergic neural bronchoconstriction inguinea-pig invivo (1988) (3)
MicroRNA-34a drives small airway fibroblast cellular senescence in COPD (2017) (3)
Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke (2012) (3)
Lack of macrophage plasticity in COPD (2012) (3)
Neuropeptides in the pathogenesis of lung inflammation. (1988) (3)
Adrenaline, But not Salbutamol Inhibits Airway Microvascular Leakage in Guinea Pigs (1988) (3)
IL-9-producing cells promote Th1 responses against Mycobacterium tuberculosis. (P3015) (2013) (3)
A Blood Test for Lung Fibrosis (2008) (3)
Chronic obstuctive pulmonary disease (2014) (3)
Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists (2015) (3)
Characterization of stereospecific binding sites for [3H]-inositol (1,4,5)-trisphosphate in airway smooth muscle. (1989) (3)
Anti-Inflammatory Therapeutics in COPD: Past, Present, and Future (2013) (3)
Other Mediators of Asthma (1998) (3)
25 – Transcription Factors (1998) (3)
[Molecular biologic aspects of chronic inflammation reaction in bronchial asthma: incentive for new therapeutic concepts?]. (1997) (3)
Inflammatory Mediators and Airway Function (1990) (3)
Drugs for the treatment of asthma and COPD (2005) (3)
Role played by NK2 receptor and cyclooxygenase activation in bradykinin B2 receptor mediated-airway effects in guinea pigs (1993) (3)
Alveolar m macrophage-induced s suppression o of p peripheral blood m mononuclear c cell rresponsiveness iis rreversed b by in v vitro allergen e exposure iin b bronchial a asthma (1994) (3)
Clinical tuberculosis : a practical handbook (2013) (3)
Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation (2015) (3)
Iconographies supplémentaires de l'article : Effects of a leukotriene receptor antagonist on exhaled leukotriene E 4 and prostanoids in children with asthma (2011) (3)
Therapeutics in Respiratory Disease (1994) (3)
Chronic obstructive pulmonary disease in non-smokers – Authors' reply (2009) (3)
Targeting Histone Deacetylases in Chronic Obstructive Pulmonary Disease (2011) (3)
Extracellular signal-regulated kinase 1/2 control Ca(2+)-independent force development in histamine-stimulated bovine tracheal smooth muscle. (2000) (3)
Mechanisms in COPD compared with asthma (2008) (3)
Airway smooth muscle and disease workshop: epithelial mediators. (1987) (3)
Bradykinin and capsaicin evoked activation of single vagal C-fibres in the guinea-pig airways in vitro (1993) (3)
Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator. (2006) (3)
Introducing Expert Review of Respiratory Medicine (2007) (3)
Elevated GM-CSF in COPD may drive defective macrophage phenotype (2014) (3)
Autoradiographic mapping of pulmonary NK1 and NK2 tachykinin receptors and changes after repeated antigen challenge in guinea pigs (1996) (3)
Mycobacterium tuberculosis culture filtrate protein of 10 kDa inhibits B cell function (P3120) (2013) (3)
Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid (ICS), Has More Potent Anti-inflammatory Effects Than Fluticasone Propionate In Peripheral Blood Mononuclear Cells From Asthma And COPD Patients (2010) (3)
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT) (2016) (2)
Zafirlukast (Accolate). (1998) (2)
Direct methods for the measurement of nitric oxide. (2001) (2)
Phosphodiesterase expression in human epithelial cells. (1998) (2)
Asthma Management – a New Dimension (1987) (2)
Effect of A Platelet Activating Factor (PAF) Antagonist (Web 2086) on Paf Induced Airway Microvascular Leakage and Platelet Aggregation (1987) (2)
Nifedipine Prolongs Isoprenaline-Induced Bronchodilatation in Normal Subjects (1984) (2)
Comprar Clinical Tuberculosis 4ed | Peter Barnes | 9780340948408 | Hodder Arnold (2008) (2)
Reduced phagocytosis of pathogenic bacteria by neutrophils from COPD patients (2012) (2)
Sensitive to modern life (2006) (2)
Addressing Unmet Medical Needs in COPD Management (2011) (2)
Modulation of neurally mediated airway microvascular leakage in guinea-pig airways byβ2 agonists (1992) (2)
Chronic Obstructive Pulmonary Disease (COPD) (2008) (2)
Respiratory medicine : recent advances (1993) (2)
Effect of a PAF Antagonist, BN52063 on Antigen-Induced Cutaneous Responses in Atopic Subjects (1988) (2)
Chapter 51 – Corticosteroids (2009) (2)
No role for ERK and p38 MAPK (2004) (2)
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD (2015) (2)
Cytokine mRNA profiles of normal and asthmatic peripheral blood cells and endobronchial biopsies. (1996) (2)
Use of medical record linkage to study readmission rates. (1989) (2)
T cell receptor repertoire in peripheral blood and bronchial biopsies from normal and asthmatic subjects. (1996) (2)
Klotho: An important protein in the formation and development of emphysema (2012) (2)
Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid (ICS), With Sustained Glucocorticoid Receptor Nuclear Translocation (2010) (2)
Catecholamines in Exercise and Hyperventilation-Induced Asthma (1980) (2)
Inhaler devices and global warming: Flawed arguments (2020) (2)
Exacerbation risk after night-time waking due to asthma in SYGMA 1 (2019) (2)
Production of 6-oxo-PGF1 alpha by human lung in vivo. (1979) (2)
Airway smooth muscle receptors. (1990) (2)
Number needed to treat (NNT) to have an additional patient free from a severe or moderate/severe exacerbation: post-hoc analysis of SYGMA 1 in mild asthma (2019) (2)
Asthma mechanisms, determinants of severity and treatment (1996) (2)
Inhibition of p38 mitogen-activated protein kinase has no effect on macrophage phagocytosis of bacteria in patients with COPD (2013) (2)
The RNA binding protein HuR regulates the senescence-associated secretory phenotype under conditions of oxidative stress (2019) (2)
The low-chloride cough response is not inhibited by a single, high dose of aspirin. (1992) (2)
Functional Characteristics of Beta-Adrenergic Receptors of the Intact Eosinophil (1989) (2)
Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD) (2016) (2)
Effects of an NK1 receptor selective antagonist, FK888, on mucus secretion in ferret trachea: Involvement of tachykinins in neural mucus secretion (1992) (2)
Meeting abstracts from the Respiratory Effectiveness Group 2015 Winter Summit – databases and registries around the world: maximizing the yield (2015) (2)
Corticosteroid Therapy in Asthma. (1961) (2)
Influence of Autonomic Blockade on Cardiovascular effects of Infused Adenosine in Man (1986) (2)
Allergen Responses Modified by a GATA3 DNAzyme. (2015) (2)
Neural Control of Airways (1992) (2)
Dilator Action of Ligustrazine on Human and Rat Pulmonary Arteries (1989) (2)
[How should clinical practice guidelines be implemented? Conclusion]. (2005) (2)
Differing Physiological Responses of Atrium and Ventricle to Adenosine: Correlation with Receptor Densities (1988) (2)
High resolution CT scan (HRCT) thorax differences between biomass-smoke exposure induced COPD (BM COPD) and tobacco-smoking COPD (TS COPD) (2012) (2)
Nitrosative stress in patients with asthma−chronic obstructive pulmonary disease overlap (2019) (2)
Breaking down barriers to lung health. (2014) (2)
Roflumilast potently inhibits CXCL1 mediated neutrophil migration in COPD patients (2011) (2)
Use of geographical information system (GIS) in prevalence studies (2014) (2)
IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD (2021) (2)
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients (2016) (2)
No Evidence Electric Charge Increases Inhaled Ultrafine Particle Deposition in Human Lungs. (2020) (2)
Anti-leukotrienes: a new treatment for asthma. (1998) (2)
Neuropeptide Y modulates non-adrenergic, non-cholinergic neural bronchoconstriction in vivo and in vitro. (1989) (2)
TRPV1 in the airways (2005) (2)
Effect of nedocromil sodium on platelet-activating factor-induced airway responses. (1993) (2)
Cigarette smoke impairs autophagic flux in bronchial epithelial cells (2013) (2)
305 A high dose of inhaled budesonide is more cost-effective than a low dose in moderate asthma (2000) (2)
Exacerbations of asthma : a descriptive study of 425 exacerbations (2000) (2)
Prospects for anti-inflammatory therapy in lung disease (1991) (2)
Lack of a role for bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig (1996) (2)
Sustained-release theophylline and nocturnal asthma, once-daily and unequal dosing schedules. (1987) (2)
COPD and Asthma: Effects Beyond the Respiratory System (2012) (2)
Mitochondrial function in three different types of airway epithelial cells (2015) (2)
Signal Transduction Pathways Involved in Glucocorticoid Actions (2010) (1)
Effect of frusemide on the induction and potentiation of cough induced by prostaglandin F2o, (2006) (1)
Autonomic Control of the Airways (2002) (1)
Changes in quality of life as assessed by St. Georges respiratory questionnaire (SGRQ) and COPD assessment test (CAT) and spirometric indices in patients with smoker-COPD(S-COPD) and non-smoker-COPD(NS-COPD) after 1 year of follow up (2014) (1)
Airway receptors and asthma. (1986) (1)
Future research in chronic obstructive pulmonary disease (2006) (1)
Adrenergic nerves and receptors (1997) (1)
The effect of methoctramine on airway cholinergic nerves in the guinea-pig (1990) (1)
Pharmacology of asthma and COPD (2013) (1)
Chronic obstructive pulmonary disease: reasons for optimism (2009) (1)
From the authors: (2009) (1)
Correction: Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic Disease (2018) (1)
Activated protein phosphatase PP2A by formoterol enhances nuclear translocation of glucocorticoid receptor induced by budesonide (2011) (1)
NFAT subtypes in regulating Th2 lymphocytes (2012) (1)
THE IMPACT OF DRUG CLEARANCE ON DURATION OF ACTION OF CORTICOSTEROIDS (2015) (1)
Autonomic Control of Airways (2004) (1)
ect of inhaled ozone on exhaled nitric oxide , pulmonary function , and induced sputum in normal and asthmatic subjects (1999) (1)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Overview (2006) (1)
Endogenous Circulating Catecholamines and Histamine in Asthmatic Subjects (1981) (1)
Interaction between airway epithelium and peptides (1991) (1)
C4 Drugs for the treatment of airway disease (2011) (1)
Histone demethylation and acetylation are involved in the epigenetic regulation of epithelial-mesenchymal transition (EMT) (2013) (1)
Altered iron metabolism and elevated cellular senescence in COPD small airway epithelial cells (2020) (1)
The Effect Of The Novel Phosphodiesterase-4 Inhibitor MEM 1414 On The Allergen-induced Responses In mild Asthma (2010) (1)
Increased Lung Epithelial Permeability to Histamine is Mediated by H2 Receptors (1984) (1)
Fluticasone furoate, a novel corticosteroid, maintains glucocorticoid receptor nuclear localisation for 24 hours after washout in monocytes (2011) (1)
Antagomir Of Microrna-34a Rescues Cellular Senescence In Bronchial Epithelial Cells Of COPD Patients (2017) (1)
Inflammatory and Immune Mechanisms in COPD (2012) (1)
Comparison of Nebulised Adrenaline and Salbutamol in Acute Severe Asthma (1986) (1)
Dual interleukin-17A/F deficiency protects against acute and chronic response to cigarette smoke exposure in mice (2021) (1)
AIRWAY MUSCARINIC RECEPTORS (1999) (1)
Elevated concentrations of CXCL8 in the nasal mucosal lining fluid of COPD patients as an accessible surrogate measure of bronchial levels (2016) (1)
Plasma Catecholamine Concentrations in Acute Severe Asthma and Antigen-Induced Bronchoconstriction (1984) (1)
Clinical Studies on New Drugs (2001) (1)
Association between quality of life as assessed by St. George's respiratory questionnaire (SGRQ), lung function indices and sputum inflammatory parameters in Indian COPD patients (2014) (1)
Chapter 52 – Mediator Antagonists (2009) (1)
NHLBI workshop summaries. Neuroimmune interactions in the lung. (1992) (1)
The effect of sensory nerve depletion on cholinergic neurotransmission in guinea pig airways. (1992) (1)
Glucocorticosteroids for Asthma: From Genes to the Clinic (2007) (1)
Comprar New Drugs And Targets For Asthma And Copd (Progress In Respiratory Research, Vol. 39) | Trevor T. Hansel | 9783805595667 | Karger AG (2010) (1)
Book Review Immunopathology of Lung Disease Edited by Richard L. Kradin and Bruce W.S. Robinson. 578 pp., illustrated. Boston, Butterworth–Heinemann, 1996. $160. 0-7506-9282-0 (1996) (1)
What Does the Future Hold for the Therapy of COPD (2014) (1)
Effect of diesel exhaust particles (DEP) on monocyte-derived macrophage (MDM) mediator release and phagocytosis in chronic obstructive pulmonary disease (COPD) (2013) (1)
1 New drugs for asthma (2004) (1)
New Drugs: Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections (1988) (1)
Neural Control of Airway Function in Asthma (1998) (1)
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]. (1980) (1)
Physiological and inflammatory phenotypic comparisons between non-smoking and smoking COPD (2013) (1)
Hypoxia and Catecholamine Secretion in Normal Man (1984) (1)
Endothelial progenitor cells in smokers are dysfunctional because of increased DNA damage and senescence (2013) (1)
Allergic Inflammatory Mediators and Bronchial Hyperresponsiveness (1990) (1)
Comprar Asthma And Copd: Basic Mechanisms And Clinical Management | Neil Thomson | 9780123740014 | Academic Press (2008) (1)
Cultured human airway epithelial cells release fibroblast mitogens: a role for insulin-like growth factor 1 (IGF-1) (1993) (1)
A breath of hot air? (2013) (1)
Activated Protein C Inhibits Bronchial Hyperresponsiveness and Th 2 Cytokine Expression in the Mouse (2003) (1)
Measurement of exhaled hydrocarbons. (2001) (1)
Preface to the 2nd Edition (2009) (1)
Therapy of Airway Disease (2012) (1)
Effects of Infused Adenosine on the Cardiovascular Responses to Orthostasis in Man (1987) (1)
New drugs for COPD based on advances in pathophysiology (2004) (1)
[Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes]. (1990) (1)
529 Increased c-fos synthesis in mononuclear cells from patients with corticosteroid resistent asthma (1996) (1)
AIRWAY NEUROPEPTIDES AND THEIR ROLE IN INFLAMMATION (1998) (1)
Anti-leukotrienes: the promise for asthma? (2000) (1)
GATA-3 MAPK-Mediated Phosphorylation of Regulation of Th 2 Cytokine Genes by p 38 and (2007) (1)
The Effects of Almitrine on Resting Ventilation and Hypoxic and Hypercapnic Drives to Ventilation in Normal Subjects (1982) (1)
Inflammatory Mechanisms in Chronic Obstructive Pulmonary Disease (2017) (1)
Airway receptors. (1989) (1)
Postnatal changes in b -adrenoceptors in the lung and the e(cid:128)ect of hypoxia induced pulmonary hypertension of the newborn (2002) (1)
Bronchial Hyperreactivity: Perspectives in Asthma: 1. (1983) (1)
AB039. Pragmatic trial stepping down Flutiform® in patients maintained on high dose ICS. (2016) (1)
[Degranulation of human eosinophilic granulocytes by the platelet activating factor]. (1990) (1)
Glucocorticoids: Pharmacology and Mechanisms (2012) (1)
Gluco corticoids preferentially increase fetal alveolar beta adrenoceptors auto radiographic evidence (1983) (1)
VISUALIZATION OF MUSCARINIC M4 MESSENGER-RNA BY INSITU HYBRIDIZATION IN RABBIT LUNG (1993) (1)
Measurement of granulocyte pharmacodynamics in whole blood by flow cytometry. (2001) (1)
Adding formoterol to budesonide in moderate asthmatics is cost saving - Results from the FACET Study (2001) (1)
Difficult asthma: Authors' reply (1989) (1)
Adrenergic and Non-Adrenergic Mechanisms in Asthma (1985) (1)
Asthma management: can we further improve compliance and outcomes? (2004) (1)
CHAPTER 8 Cells and mediators of chronic obstructive pulmonary disease (2006) (1)
Superior Anti-inflammatory Effects Of A Novel Macrolide/fluoroketolide, CEM-101, In Monocytic Cells (2010) (1)
The Effect of Vasoactive Intestinal Peptide on Human Airway Smooth Muscle in-vitro (1985) (1)
RNA-binding protein HuR inhibits the expression of sirtuin-1 in patients with COPD (2017) (1)
Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects (2012) (1)
Molecular biology of receptors in the respiratory tract (1993) (1)
ADENOSINE AND HYPERTROPHIC CARDIOMYOPATHY (1989) (1)
Spatial distribution of COPD in a rural population in India using geographic information system (GIS) (2011) (1)
NEW PROSPECTS IN THE TREATMENT OF ASTHMA (1995) (1)
Angina pectoris-like pains provoked by intravenous adenosine (1986) (1)
Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells (2013) (1)
Role of Endogenous Opiates in Control of Breathing (1981) (1)
Role of CBP in glucocorticoid-induced gene repression. (1998) (1)
Introducing a new series: Giants in chest medicine. (2013) (1)
UK CASE OF AIDS IN AN INTRAVENOUS DRUG ABUSER (1985) (1)
Airway neuropeptides and airway disease. (1987) (1)
The cardiovascular effects of nebulized adenosine in man (2004) (1)
DURATION OF ACTION 0E OXITROPIUM BROMIDE (1985) (1)
Adrenoceptor Agonist-Induced Upregulation of Tachykinin NK 2 Receptor Expression and Function in Airway Smooth Muscle (1999) (1)
Inflammatory airway diseases and clinical allergy (2010) (1)
The Influence of Epithelium on Airway Smooth Muscle Contraction (1985) (1)
Reduced Acetylation of Histone 4 in Corticosteroid-Resistant and Corticosteroid-Dependent Asthma (2001) (1)
Eosinophils and airway hyper-responsiveness (2001) (1)
Comparison of quality of life in smoking and non-smoking COPD patients in India using St. George's respiratory questionnaire and COPD assessment test (2013) (1)
Erratum to “Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness” [Eur. J. Pharmacol. 452 (2002) 123–133] (2002) (1)
Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation (2015) (1)
RESEARCH Biomarkers in Lung Diseases: From Pathogenesis to Prediction to New Therapies Decreased phosphatase PTEN ampliﬁes PI3K signaling and enhances proinﬂammatory cytokine release in COPD (2017) (1)
An Activator Of AMP Activated Kinase (AMPK) Restores Nrf2 Protein Levels Decreased By Chronic Cigarette Smoke Exposure (2012) (1)
Drugs for asthma. (2006) (1)
Cell-Surface Receptors in Airway Smooth Muscle (1989) (1)
Non-adrenergic bronchodilatation. (1986) (1)
Mechanisms of action of glucocorticoids in asthma. Discussion (1996) (1)
Effect of 8-iso-prostaglandin F(2 alpha) on acetylcholine release from parasympathetic nerves in guinea pig airways. (2001) (1)
Ligand-induced di(cid:128)erentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF- k B and lack of I- k B involvement (1999) (1)
Genomics in the Evaluation and Management of Chronic Obstructive Pulmonary Disease (2010) (1)
Bradykinin-Induced Microvascular Leakage in Guinea Pig Airways: Involvement of Platelet Activating Factor and Prostanoids (1988) (1)
Contents, Vol. 94, 1991 (1991) (1)
Differential Effect of Inflammatory Mediators on Microvascular Permeability in Different Parts of the Guinea Pig Airways (1988) (1)
Sensory nerve depletion potentiates non-adrenergic, non-cholinergic inhibitory nerves in guinea-pig trachea. (1989) (1)
TNFα release by monocyte-derived macrophages at stable and exacerbation states in COPD (2014) (1)
The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma (2013) (1)
Detection of STAT1 phosphorylation in COPD sputum by flow cytometry (2013) (1)
Efficacy of as-needed budesonide/formoterol in mild asthma: pooled analysis of SYGMA 1 and 2 (2020) (0)
There is no need for complicated equations and mathematical models. Exhaled nitric oxide can be partitioned with two simple exhalations (2011) (0)
Impulse oscillometry measurements are correlated to quality of life in patients with pulmonary sarcoidosis (2014) (0)
COPD lung contains a sub-population of steroid-insensitive macrophages (2011) (0)
Transcription factors (1995) (0)
Reply to Racké, et al (1996) (0)
Long-Acting Inhaled Bronchodilators: The Mainstay of COPD Management (2016) (0)
Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages (2014) (0)
Pharmaceutical composition containing resveratrol for the treatment of inflammatory disorder of respiratory ways (2001) (0)
Increased uptake ofhaemophilus influenzaeby primary airway epithelial cells from COPD patients (2016) (0)
Autonomie Receptors in the Upper and Lower Airways (2017) (0)
Assessment of Respiratory Responses (2020) (0)
Recent Thymic Emigrants Do Not Account for the Increased Number of TCells Seen in the Lungs of Stable Chronic Obstructive Pulmonary Disease (2008) (0)
Involvement ofinflammatory mediators intheairway responses totrimellitic anhydride insensitized guinea-pigs (1992) (0)
The trials and tribulations of anti-IL-5 em leader. (2002) (0)
Management of Chronic Asthma (2009) (0)
DEVELOPMENT OF THE SHORT BASIC TEST BATTERY FORM SB-3. (1966) (0)
Evaluation of new drugs for asthma and COPD: Endpoints, biomarkers and clinical trial designs (2004) (0)
New Drugs for the Treatment of Allergy and Asthma (2009) (0)
21 – Pathophysiology of Allergic Inflammation (2014) (0)
A New Simple Method To Partition Central Airways And Peripheral Exhaled Nitric Oxide (2012) (0)
REVIEW Difficult asthma (2002) (0)
hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats (1991) (0)
Review Th2 cytokines and asthma: an introduction (2001) (0)
GATA-3 nuclear import plays a critical role in regulating Th2 cytokine gene expression (2004) (0)
Pharmacological Control of Eosinophil Activation and Secretion (2019) (0)
New aspects of asthma. (1992) (0)
Biographical Sketch of Dr. Alec H. Sehon (1991) (0)
LSC - 2020 - Extracellular vesicles produced by bronchial epithelial cells in response to oxidative stress contain micro-RNAs associated with senescence (2020) (0)
A Comparison of the Cutaneous Actions of Substance P and Calcitonin Gene Related Peptide in Man (1986) (0)
dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease : study protocol for a randomised controlled trial (2015) (0)
Tuberculosis in Special Situations (2008) (0)
Recent Advances in Asthma Management (2018) (0)
Respiratory Research: a new multidisciplinary journal for a new age (http://respiratory-research.com) (2000) (0)
Nonantimicrobial aspects of therapy. (2000) (0)
Metformin regulates sirtuin expression in airway epithelial cells (2018) (0)
COPD7, Birmingham UK, 30 June–2 July 2010 (2011) (0)
Involvement Of P38MAPK Gamma On Corticosteroid Refractory Airway Inflammation Induced By Tobacco Smoke In Mice (2010) (0)
The Application of Analytical Technique Applied to Expired Air as a Means of Monitoring Airway and Lung Function (2020) (0)
Accelerated ageing in COPD: New insights and targets (2018) (0)
No evidence electric charge increases inhaled ultrafine particle deposition in human lungs (2020) (0)
Prof. Dr. med. Chris T. Bolliger (2012) (0)
Title Pages / Table of Contents / Corresponding Authors / Foreword / Preface (2010) (0)
Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid, Is More Potent Than Fluticasone Propionate And Budesonide In Human Respiratory Cell Lines (2010) (0)
Updates in Chronic Obstructive Pulmonary Disease for the Year 2014. (2015) (0)
TUESDAY, SEPTEMBER 27TH 2011 407. Immunology and cell biology of asthma and COPD (2011) (0)
Abstracts of the European Symposium on Smooth Muscle (2005) (0)
What are the Mechanisms of Corticosteroid Resistance in Asthma (2008) (0)
CHAPTER 9 Noninvasive assessment of airway inflammation in asthma (2003) (0)
Nitric Oxide in Exhaled Air: Relevance in Inflammatory Lung Disease (2000) (0)
Quantitative measurements of regional ventilation/perfusion ratios by means of positron emission tomography. (1985) (0)
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function". (2021) (0)
The remote collection and storage of exhaled gas is complicated by production of NO by exhaled bacteria: A solution to this problem (1998) (0)
Effects of alterations in intracellular and extracellular calcium on ion transport in guinea pig trachea in vitro (1988) (0)
Is inhaler technique adequately assessed and reported in clinical trials of asthma and COPD therapy? A systematic review and suggested best practice checklist. (2022) (0)
JAMA Peer Reviewers in 2004 (2016) (0)
Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation (2017) (0)
Reviewer Acknowledgment (2012) (0)
AB038. Pragmatic trial comparing continuing Seretide® MDI with changing to Flutiform® in asthma. (2016) (0)
From pathophysiological mechanisms to pharmacological treatment of childhood asthma (1995) (0)
The ffate oof rrespiratory pphysiology (1994) (0)
Hypoxia Inducible Factor-1α binding to HDAC2 and MIF promoter regions is associated with changes in gene expression levels in chronic ozone exposed mice (2011) (0)
Interleukin-6, obstructive sleep apnea, and obesity. Authors' reply (2003) (0)
Subject Index Vol. 72, 2005 (2005) (0)
Morphine inhibits non adrenergic non cholinergic neurogenic microvascular leakage in guinea pig airways in vivo (1988) (0)
S52 Association of microtubule instability with defective phagocytosis in COPD (2011) (0)
Effect Of Vocal Cord Adduction On Forced Oscillometry Parameters (2012) (0)
New Device for Airflow Measurement: Comparison with Pneumotachograph and Differentiated Respitrace Volume (1984) (0)
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis (2015) (0)
The effects of low temperature, short time diffusion of zinc on the transport properties of GaAs. (1996) (0)
Abstracts of papers clinical pharmacological meeting (2005) (0)
Meeting the needs of special patient groups: The contribution of leukotriene receptor antagonist therapy for asthma in the elderly (1998) (0)
Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in COPD (2015) (0)
Sputum neutrophil mediators in experimental rhinovirus infection in COPD (2013) (0)
Chapter 61 – Future Therapies (2009) (0)
Production of 6-Keto PGF1αby Human LungIn Vivo (1980) (0)
Elevated osteoprotegerin in COPD is potentially regulated by oxidative stress dependent glycogen synthase kinase-3β and β-catenin signalling (2011) (0)
JAK/STAT inhibition improves macrophage phagocytosis of bacteria (2011) (0)
Serum sirtuin-1 is reduced in COPD (2016) (0)
Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial (2018) (0)
GATA-3Phosphorylation of Regulation of Th2 Cytokine Genes by p38 (2013) (0)
3. SIGNIFICANCE OF TREATMENT OF AIRWAY INFLAMMATION IN ASTHMA (1992) (0)
ANTIMALARIAL DRUGS AND BURKITT'S LYMPHOMA (1974) (0)
Molecular Mechanism Of Poor Hypoxia Inducible Factor 1± Response To Hypoxia In Chronic Obstructive Pulmonary Disease (2012) (0)
Modulation of Functional Pulmonary β2-Adrenoceptor by Tansforming Growth Factor-β1 in Human Bronchial Epithelial Cells (2005) (0)
PI3 kinase Inhibition Reduces Uptake of Haemophilus Influenzae by Airway Epithelial Cells (2017) (0)
Oxidative stress and cardiovascular complications in sleep apnea. Author's reply (2005) (0)
Successful Primary Care Management of COPD (2013) (0)
Differential phosphorylation patterns of macrophage cytoskeletal proteins in COPD following phagocytosis (2019) (0)
4 Non-invasive monitoring of asthma and COPD (2005) (0)
THE MOLECULAR BASIS OF INFLAMMATION Chronic inflammatory diseases (2006) (0)
Effect of selective tachykinin agonists on mucus secretion and smooth muscle contraction in ferret airways (1992) (0)
vascular responses Peroxynitrite does not impair pulmonary and systemic (2015) (0)
An In Vitro Monocyte Washout Model To Determine Molecular Differences Between Short And Long-Acting Inhaled Corticosteroids (ICS) (2012) (0)
Rescue Treatment in Asthma: Response (2010) (0)
Acute effects of flutter breathing exercises on exhaled nitric oxide and airway resistance (2013) (0)
Influence of Prior Treatment Upon the Efficacy of As-Needed Budesonide/Formoterol in Mild Asthma in the SYGMA 1 and 2 Studies (2019) (0)
A Novel Macrolide/fluoroketolide, CEM-101, Reverses Corticosteroid Insensitivity Under Oxidative Stress Via PI3K Pathway Inhibition (2010) (0)
Comparison ofneurokinin A andsubstance Poncardiovascular andairway function inman (1988) (0)
Homologous and heterologous regulation of M2 muscarinic receptors and m2 receptor gene expression (1995) (0)
Plasma catecholamine concentrations in asthma (1985) (0)
Exhaled Nitric Oxide in Clinical Practice: Recent Advances and New Challenges (2013) (0)
Inhaled frusemide and asthma (1990) (0)
Plasma catecholamines in exercise-induced asthma (1981) (0)
5 WHAT ARE THE PREFERRED SECOND-LINE MEDICATIONS TO BE COMBINED WITH INHALED CORTICOSTEROIDS? (2002) (0)
Reduced SIRT1 Leads To Increased Th2 Cytokine Expression Via Hyper-acetylation Of GATA3 (2010) (0)
2 Mechanisms of disease (2007) (0)
Dietary constituents and COPD (2011) (0)
New treatments for chronic obstructive pulmonary disease. (2001) (0)
464 CD4+ but not CD8+ T cells transfer allergic airway hyperresponsiveness (AHR) in BN-rats (1996) (0)
Iconography : Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease (2018) (0)
NDP52 inhibition rescues cigarette smoke mediated impairment of autophagy in macrophages (2016) (0)
4. NEURAL MECHANISMS OF BRONCHIAL HYPERRESPONSIVENESS (1992) (0)
In viro in vivo correlations for a short acting bronchodilator using artificial neural networks. (2009) (0)
Chapter 32 – Neural and Humoral Control of the Airways (2009) (0)
Effect ofan inhaled histamine H3-receptor agonist on airway responsestosodium metabisulphite inasthma (1993) (0)
COPD Small Airway Fibroblasts show reduced proliferation rate and are arrested in G1 phase (2019) (0)
COPD and asthma: similarities and differences (2012) (0)
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease (2021) (0)
Gene regulation of muscarinic receptor subtypes (2001) (0)
Prevention of death in COPD. (2007) (0)
PAF Antagonists (1988) (0)
Effects of theophylline on airway eosinophils. Authors' reply (2002) (0)
Future therapies for chronic obstructive pulmonary disease (2006) (0)
Loss of Nrf2 mediated anti-oxidant protection in chronic ozone exposure model of COPD (2011) (0)
Contents, Vol. 99, 1992 (1992) (0)
Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid (ICS), Has Superior Anti-inflammatory Effects Compared To Fluticasone Propionate Under Conditions Of Oxidative Stress (2010) (0)
Detection of air leaks and their effects on forced oscillometry measurements (2012) (0)
Respiratory Medicine: The GP Guide to Secondary Care Investigations (2000) (0)
Body mass impacts distal airway function (2014) (0)
Chemokine receptor CCR1: new target for asthma therapy. (2022) (0)
JAK inhibitors overcome corticosteroid insensitivity in COPD (2011) (0)
News Review: Lipid Technology 1/2007 (2007) (0)
Standardization of the two compartment model for the partitioning of exhaled NO: Effect of different flows and breath-hold periods (2013) (0)
mechanical impedance: a model study Effect of expiratory flow limitation on respiratory (2015) (0)
New aspects of chronic obstructive pulmonary disease (2007) (0)
Differentiation of macrophages with cigarette smoke extract alters bacterial phagocytosis (2016) (0)
Sirtuin 1 reduction causes activation of Wnt/b catenin signalling (2011) (0)
Neuropeptides in respiratory medicine (2017) (0)
Macrophage phenotype does not affect protease anti-protease imbalance in COPD (2015) (0)
Differential cigarette smoke and H2O2induced cytokine release from macrophages in COPD (2015) (0)
Phenotypic comparison of glucose and cardiac physiology of biomass fuel induced and smoking induced COPD (2013) (0)
Drugs for the Treatment of Respiratory Diseases: Glucocorticosteroids (2003) (0)
IL-15 and DAP-10 mediated IL-22 production by Natural Killer cells in human Mycobacterium tuberculosis-infection. (134.7) (2009) (0)
Rebuttal From Dr Barnes. (2017) (0)
Chronic Obstructive Pulmonary Disease (COPD): Biological Mechanisms (2008) (0)
New pharmacological therapies for COPD (2012) (0)
Giants in Chest Medicine: Leonardo M. Fabbri, MD. (2014) (0)
Chapter-046 Treatment of Chronic Obstructive Pulmonary Disease (2012) (0)
ESAT-6 inhibits IL-12, but promotes IL-23 production of human dendritic cells (56.9) (2011) (0)
Exhaled breath markers in COPD (2004) (0)
Correction (2018) (0)
Distribution of Beta-Adrenoceptor Subtypes in Human Lung (1985) (0)
Small airways and exercise-induced bronchoconstriction (EIB) in elite athletes (2014) (0)
Comprar COPD in Clinical Practice | Barnes, Peter J. | 9781848820807 | Springer (2009) (0)
A useful introduction to a rapidly advancing field (2001) (0)
Dexamethasone action on c-fos and c-jun mRNA and protein in human lung. (1994) (0)
Cellular and Biochemical Aspects of Airway Hyperresponsiveness (1992) (0)
A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via activation of protein phosphatase PP2A (2011) (0)
Endoplasmic reticulum stress implication in senescence of small airway fibroblasts from COPD patients (2020) (0)
Acetylcholinesterase Inhibition: A Probe for Investigating Cholinergic Control of Human Airways (1984) (0)
Managing asthma inhospital: cause forconcern (1991) (0)
Alpha-adrenoceptor binding in guinea-pig lung using [3H]-prazosin [proceedings]. (1980) (0)
Nitric oxide and lung disease Vasodilator Cytokines Steroids Cytokine W receptor (2004) (0)
Mechanism of Glucocorticoid Action: Effects on Chromatin Structure (2000) (0)
Cross talk between M2-muscarinic and beta-2-adrenergic receptors in HEL 299 cells (1995) (0)
Calcium-channel blockers andasthma (1983) (0)
350 Cyclic AMP-elevating agents prolong the survival of human eosinophils in culture (1996) (0)
Appendix 1 – Extraction and Analysis of Cereal Lipids (1983) (0)
LSC Abstract – Rhinovirus infection induces NRF2 in monocytes but not in epithelial cells, via distinct intracellular pathways (2015) (0)
2 CYTOKINE-DIRECTED THERAPIES IN ASTHMA (2002) (0)
Chapter 62 – Future Therapies (2002) (0)
Formoterol restores oxidative stress-induced corticosteroid insensitivity via activation of protein phosphatase PP2A (2012) (0)
The Clinical Consultation (2011) (0)
News Review: Lipid Technology 5/2007 (2007) (0)
New Approaches to Corticosteroid Resistance (2014) (0)
Corticosteroids improve lung function and quality of life in subjects with biomass fuel (BMF) smoke exposures induced COPD (2015) (0)
Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD (2014) (0)
How To Design a Negative Study (2003) (0)
The future : treating specific endotypes (2016) (0)
The Effect of Hypoxia on Pulmonary Endothelial Derived Vasoactive Agents (1989) (0)
A role of mTOR in cigarette smoke-induced corticosteroid insensitivity (2012) (0)
A novel flow cytometric based method to measure kinase inhibition in sputum from COPD subjects (2016) (0)
Defective macrophage phagocytosis in COPD is associated with reduced STAT1 phosphorylation (2012) (0)
blood flow in humans A simplified noninvasive method to measure airway (2015) (0)
Stable isotope labelled amino acid culturing: A novel approach to identify pathways involved in MIF signalling (2013) (0)
role of cyclooxygenase products . bronchoconstriction by frusemide in asthma : Inhibition of sodium metabisulphite induced (2004) (0)
Contents, vol. 50, Supplement 2, 1986 (1986) (0)
The Launch of a New COPD Journal. (2014) (0)
DOSE-RESPONSE CURVES TO INHALED p-ADRENOCEPTOR AGONISTS IN NORMAL AND ASTHMATIC SUBJECTS (2006) (0)
Sensory neurophysiology of the cough reflex. Discussion (1996) (0)
Interleukin-6, Obstructive Sleep Apnea, and Obesity (2003) (0)
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling (2014) (0)
Female Sex Hormones Modulate Inflammatory Mediator Expression From Bronchial Epithelial Cells (2010) (0)
News Review: Lipid Technology 3/2007 (2007) (0)
Formoterol Regulates Nuclear Translocation Of Glucocorticoid Receptor By Direct Activation Of Protein Phosphatase Pp2a (2011) (0)
Respiratory andallergic disease. I. (1988) (0)
829 Eotaxin induces an increase in nasal nitric oxide via eosinophil recruitment and oxidative stress in patients with allergic rhinitis (2000) (0)
Eosinophils adheretoandstimulate replication oflungfibroblasts 'invitro' (1991) (0)
A breath of hot air? [Editorial]. (2013) (0)
Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial (2022) (0)
Overview of Nocturnal Asthma (1987) (0)
Antispasmogenic activity of phosphodiesterase inhibitors in guinea-pig trachea (1995) (0)
Inhaled corticosteroids in asthma. Authors reply (1994) (0)
Local and central reflex mechanisms in the neural control of airway mecrocirculation. Discussion (1990) (0)
Duplicate publication. (2002) (0)
Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects (2016) (0)
Altered steroid binding in PBMC corellates strongly with steroid in-sensitivity in patients with difficult asthma (2000) (0)
Inflammatory Markers: Exhaled Nitric Oxide and Carbon Monoxide During the Ovarian Cycle (2011) (0)
Book Review Nocturnal Asthma: Mechanisms and Treatment Edited by Richard J. Martin. 394 pp., illustrated. Mount Kisco, N.Y., Futura, 1993. $72. 0-87993-546-4 (1994) (0)
Transcriptional regulation of β2-adrenergic receptor gene expression by TGF-β1 in a human embroyonic lung fibroblast cell line (1995) (0)
Lung Epithelial and Endothelial Permeability in Smokers, Non-Smokers and Patients with ARDS (1985) (0)
Nitic oxide and asth-matic inflammation (1995) (0)
Arachidonic Acid Mobilization Mechanism That Is Largely Independent of Eosinophils by a Pertussis Toxin-Sensitive Activates the NADPH Oxidase in 4 Leukotriene B (1998) (0)
cytokine expression in the mouse Activated protein C inhibits bronchial hyperresponsiveness and Th 2 (2003) (0)
Inflammatory Mediators and Neural Mechanisms in Severe Asthma (2001) (0)
Nocturnal asthma. (1988) (0)
ILV1 New drugs for asthma and COPD (2006) (0)
Junior Hospital Staff Contract (1975) (0)
Chapter 49 – Anticholinergic Bronchodilators (2009) (0)
Montelukast for persistent asthma [3] (multiple letters) (2001) (0)
Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells (2011) (0)
Giants in chest medicine: Margaret Turner-Warwick, DBE, DM, PhD. (2014) (0)
News Review: Lipid Technology 2/2007 (2007) (0)
Results of a phase 2a clinical trial with a peptide inhibitor of MARCKS protein indicate improvement of indices of bronchitis and lung function in patients with COPD (2011) (0)
Passive Smoking Impairs Histone Deacetylase-2 In Alveolar Macrophages In Children With Severe Asthma (2011) (0)
Spinal anaesthesia for paediatric radiotherapy. (1980) (0)
Subject Index, Vol. 24, 1982 (1982) (0)
Y THERAPY FOR ASTHMA (1993) (0)
PROCEEDINGS OF THE EUROCONFERENCE 'HYGIENE AND HEALTH' (2001) (0)
The European Association for Bronchology and Interventional Pulmonology Is in Mourning (2012) (0)
Fluticasone Furoate, a Novel Ultra-Long Acting Corticosteroid, Has a Prolonged Inhibitory Effect on H2O2-Induced Phosphorylation of p38 MAP Kinase Compared to That of Fluticasone Propionate. (2009) (0)
A novel target of formoterol, a dual-specificity phosphatase DUSP4 on regulation of corticosteroid budesonide sensitivity (2011) (0)
IL11 New Molecular Targets for Allergy (2008) (0)
EVS1-3 Reversing Steroid Resistance in COPD and Severe Asthma : a New Therapeutic Strategy (2008) (0)
Nitrosative and oxidative stress in virus-induced COPD exacerbations (2013) (0)
Chapter 36 – β2-Agonists, Anticholinergics, and Other Nonsteroid Drugs (2008) (0)
Comparison of electronic cigarette vs. cigarette smoke extract on macrophage function (2017) (0)
Glucocorticoid Receptor Acetylation in Patients with COPD. (2009) (0)
Successful Primary Care Management of COPDContents (2013) (0)
Future Treatment of Respiratory Diseases: Regulation of Specific Gene Expression (1997) (0)
Chapter 51 – Theophylline (2002) (0)
Chapter 75 – Chronic Obstructive Pulmonary Disease (2013) (0)
Therapeutic Impact of Rosiglitazone and Low Dose Theophylline in Smokers with Asthma (2008) (0)
Chris T. Bolliger: An Obituary (2012) (0)
Barnes and Adcock reply (1994) (0)
Mice lacking tissue factor in myeloid cells are susceptible to Mycobacterium tuberculosis infection (P1243) (2013) (0)
STEROID RESISTANCE AND FATAL ASTHMA (1998) (0)
Neurogenic Inflammation in Allergic Disease (1998) (0)
Comparison of fluticasone propionate and budesonide on phagocytosis of common respiratory pathogens in COPD patients (2011) (0)
Plasminogen Activator Inhibitor-1 In Sputum Is Elevated By Oxidative Stress Dependent NF-kB Activation In Chronic Obstructive Pulmonary Disease (2011) (0)
Mediastinal paraganglioma presenting as an intracardiac mass with SVC obstruction (0)
The species-specific inflammatory response of colonising bacteria in stable COPD (2013) (0)
Proximal Promoter B Binding κ Differential Requirement for NF-) Expression : 2 AAdenosine Receptor ( A Regulation of the α and TNF-β IL-1 (2006) (0)
MYSS: should we alter clinical practice? (2004) (0)
SLAM activation induces ERK and CREB phosphorylation that leads to IFN-{gamma} production during active tuberculosis (TB) (2010) (0)
A simple practical method to partition lung peripheral and airway nitric oxide (2012) (0)
Nitric oxide in lung disorders (1994) (0)
Effect Of Short-term (3 Day) Cigarette Smoke-exposure In Mice On Histone Deacetylase (HDAC)2 And Hypoxia Inducible Factor (HIF)-1± Function (2010) (0)
from Elsevier Journals--Current Opinion in Pharmacology 抗ロイコトリエン薬の今後 (2004) (0)
Enhancing Nrf2 By Sulforaphane Improves Glucocorticosteroid Responses In COPD (2012) (0)
Endothelial Colony Forming Cells Are Senescent And Dysfunctional In Cigarette Smokers And Patients With COPD; Evidence Of Endothelial Dysfunction Due To Cigarette Smoking-Oxidative Stress (2012) (0)
Professor Neil Pride (2017) (0)
Greater Reactance with Abnormal Small Airway Compliance Measured by Impulse Oscillometry in COPD Compared to Asthmatic Patients. (2009) (0)
Chapter 5 – Biology and Assessment of Airway Inflammation (2006) (0)
43 – Future Therapies for Asthma (1998) (0)
List of contributors vii Preface xi Part I Asthma and COPD 1 Pathology of asthma and COPD : 3 inflammation and structure (2003) (0)
β-Adrenoceptor Agonists: Mode of Action (1987) (0)
Protein tyrosine phosphatase PTPRR regulates PP2A in mononuclear cells (2014) (0)
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD (2013) (0)
14.9 – Synthetic Resins (1994) (0)
Contribution of M 2 and M 3 Muscarinic Receptors in Small Airway Contraction. (2009) (0)
Professor Neil B. Pride (1931–2016) (2017) (0)
Chapter 52 – Corticosteroids (2002) (0)
Recurrent cigarette smoke exposure impairs SIRT1 shuttling in bronchial epithelial cells (2016) (0)
Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1β induced CXCL8 (2013) (0)
Mitochondrial antioxidants decrease oxidative stress and inflammation induced bronchial epithelial cell line (2016) (0)
Occasional review Cytokines in asthma (1999) (0)
27 – Pathophysiology of Asthma (1998) (0)
from the lung Importance of airway blood flow on particle clearance (2015) (0)
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages (2016) (0)
Effect of tachykinins on secretory event rate in cultured guinea-pig tracheal epithelial cells (1992) (0)
Tachykinin-induced airflow obstruction and microvascular leakage attenuate in immature airways (1992) (0)
Late endothelial progenitor cells are senescent and dysfunctional in COPD due to reduced sirtuin-1 levels (2011) (0)
Salmeterol/Fluticasone Propionate Combination (1999) (0)
E V ect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects (1999) (0)
Induced sputum microbiome in smoker and non-smoker COPD subjects and its association with lung function in Indian subjects (2017) (0)
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD (2016) (0)
News Review: Lipid Technology 4/2007 (2007) (0)
Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid, Has A Longer Duration Of Anti-inflammatory Action Than Fluticasone Propionate And Budesonide (2010) (0)
LSC Abstract – GM-CSF drives human lung tissue macrophages towards a more pro-inflammatory phenotype (2016) (0)
Book Review: Bronchial Hyperreactivity (1983) (0)
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice (2016) (0)
Comparison of budesonide and fluticasone propionate on COPD macrophage phagocytosis and killing of bacteria (2014) (0)
Sensory and Inflammatory Peptide Receptors in Airways (2020) (0)
TRPV 1 in the airways (0)
News Review: Lipid Technology 6/2007 (2007) (0)
Monocyte sub-populations do not reflect differences in COPD macrophage phenotype (2015) (0)
COPD : burden of disease , imaging and management (2011) (0)
Impaired protein tyrosine phosphatase PTPRR reduces response to corticosteroid in mononuclear cells (2013) (0)
Gene theraphy in inflammatory diseases (edited by C.H. Evans and P.D. Robbins) (2001) (0)
The Pathogenesis and Treatment of Asthma as an Inflammatory Disease (2000) (0)
Differential autoradiographic localization of leukotriene binding sites in guinea pig airways. (1987) (0)
Mast cell effector mechanisms. Discussion (1996) (0)
Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages (2016) (0)
Recent advances inasthma (1992) (0)
Allergic Respiratory Inflammation and Remodeling (2016) (0)
Methylxanthines and Phosphodiesterase in Hibitors (2008) (0)
Concordance between airway inflammation and health status in COPD patients with bacterial colonisation (2013) (0)
eosinophil but not neutrophil apoptosis Caspase-catalyzed cleavage and activation of Mst1 correlates with (2013) (0)
Exhaled nitric oxide in pulmonary diseases: a comprehensive review | NOVA. The University of Newcastle's Digital Repository (2010) (0)
Autonomic receptors (1991) (0)
Chapter 40 – Drugs (2009) (0)
Other Mediators of Airway Disease (2002) (0)
Modulation de l'histone deacetylase (2001) (0)
Novel Anti-inflammatory Therapies (2004) (0)
Late-breaking abstract: HRCT comparisons of tobacco smoking (TS-COPD) and biomass smoke induced COPD (BS-COPD) phenotypes from an Indian rural setting (2014) (0)
Nasal Challenge with Hypertonic Saline (HTS) and Assessment of Neural Reflex Activation (NRA). (2009) (0)
Location of beta(1) & beta(2)-adrenoreceptors in the developing porcine lung (1999) (0)
Microtubule Instability in COPD Leads to Defective Macrophage Phagocytosis of Bacteria. (2009) (0)
About the Authors (2003) (0)
896 Exhaled breath profile of inflammatory and oxidative markers in lung diseases (2000) (0)
Increased Deposition Of Activated Complement In Peripheral Lung Vessels Of Smokers (2010) (0)
Pathophysiology and clinical presentations of cough. Discussion (1996) (0)
Nocturnal asthma. (1987) (0)
[Pathogenetic importance of eosinophilic granulocytes. II. Hypereosinophilic diseases]. (1988) (0)
Nitrosative stress in ACO. (2019) (0)
PHOSPHODIESTERASE INHIBITORS: WILL THEY REPLACE THEOPHYLLINE? (1993) (0)
Contributors (2006) (0)
Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma (2011) (0)
Histamine levels following adenosine monophosphate challenge (2005) (0)
Substance P Enhances the Transient Ventilatory Hypoxic Response in Man (1985) (0)
ESAT-6 from Mycobacterium tuberculosis inhibits T cell IFN-{gamma} production through p38 MAP kinase pathway (2011) (0)
Bromodomain and extra-terminal (BET) proteins regulate antioxidant gene expression (2013) (0)
DJ-1 and its anti-oxidative stress response regulates the expression of sirtuin-1 in COPD epithelial cells (2017) (0)
169 Protein kinase C isoenzymes in airway smooth muscle (1997) (0)
Induction Of Wnt4 And Its Role In Inflammation In COPD (2012) (0)
DECREASED MACROPHAGE FUNCTION IN COPD (2009) (0)
Inhibition of dynein motors improves macrophage phagocytosis in COPD (2017) (0)
Epithelial Cell and Lung Cancer: Introduction (2010) (0)
C0mposicipon pharmaceutical comprising resveratrol to treat inflammatory disorders repiratorios. (2001) (0)
Failure to thrive (2008) (0)
p38 MAPK inhibitors in COPD (2012) (0)
Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release (2013) (0)
Effects Of PF-956980, A Pan JAK Inhibitor, On Glucocorticosteroid Resistant Release Of CXCR3 Chemokines From Human bronchial Epithelial Cells (2010) (0)
Molecular biology. Inflammatory activities. (1991) (0)
Airway mucosal blood flow : response to automonic and inflammatory stimuli. Discussion (1990) (0)
Chapter 53 – Mediator Antagonists (2002) (0)
CHAPTER 90 – Genomic Aspects of Chronic Obstructive Pulmonary Disease (2009) (0)
Increased α- and Reduced β-Adrenoreceptor Numbers in Experimental Asthma (1980) (0)
Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress (2013) (0)
Chapter 33 – Pathophysiology of Asthma (2009) (0)
Inhibition of Th2 Cytokine Production from Differentiated T Cells by a Novel Anti-Inflammatory Agent. (2009) (0)
Inhibition ofinterleukin-8 expression bydexamethasone inhuman cultured airwayepithelial cells (1993) (0)
ESSENTIALS OF COPD ESSENTIALS OF COPD (2005) (0)
Increased Expression Of Aquaporin 5 In Bronchial Glands Of Smokers With Or Without COPD (2010) (0)
Long-Acting Inhaled Beta2 Receptor Agonist Drugs (2020) (0)
Novel targets and therapies in COPD (2012) (0)
o-Adrenoceptor binding in guinea-pig lung using [3H]-prazosin (2007) (0)
EVS7-4 Scientific rationale for combination inhalers (2006) (0)
Contents Vol. 72, 2005 (2005) (0)
Do ICS/LABA fixed combinations provide superior asthma control compared to separate inhalers? (2010) (0)
Accelerated Lung Aging and Cellular Senescence in COPD (2020) (0)
SERIES "NONINVASIVE MONITORING OF AIRWAY INFLAMMATION" Edited by H. Magnussen and F.E. Hargreave Number 4 in this Series Clinical aspects of exhaled nitric oxide (2000) (0)
41 – Mediator Antagonists (1998) (0)
Steroids Selectively Increase β-Adrenoceptors in Foetal Alveoli: Autoradiographic Evidence (1983) (0)

This paper list is powered by the following services:

Other Resources About Peter Barnes

What Schools Are Affiliated With Peter Barnes ?

Peter Barnes is affiliated with the following schools: